Gordon Li, MD

4.9/5

31 Patient Ratings

222 Patient Reviews

Professional Summary

Education & Certifications

Residency: Stanford University Dept of Neurosurgery (2011) CA
Internship: Stanford University Dept of Neurosurgery (2005) CA
Medical Education: University of California Davis School of Medicine (2004) CA
- Board Certification: American Board of Neurological Surgery, Neurosurgery (2014)
- Bachelor of Science, Brown University, Neuroscience (1999)

View More Education & Certifications

Honors & Awards

Center for Brain and Behavior Awards in Pediatric Neurosciences (co-investigator), Lucile Packard Children's Hospital (2009-2011)
Disease Team Therapy Development Planning Award (Planning Investigator), CIRM (DR2-05373) (2011-2012)
Efficacy of using the Inovivo system to and checkpoint inhibitor treatment in GBM mouse models, Novocure (PI) (2023-2025)
- Ernest Gold Award, University of California, Davis (2001)
- Grand Opportunity Grant (co-investigator), NIH (RC2CA148491-01) (2009-2011)
- Junior AOA, University of California, Davis (2002)
- K08 Mentored Research Grant: PI, NIH-KNS085333A (2013-2018)
- Michael Edwards Resident Teaching Award, Stanford University Department of Neurosurgery (2017)
- Multi-scale modeling of glioma for prediction of tx response, tx monitoring and tx allocation, NIH R01CA26027101 Co-investigator (PI Gevaert) (May 2021 to April 2026)
- NIH R01 CA239257-01A1 Optical imaging to improve surgery and targeted therapy in brain tumors, National institutes of health (PI) (2019-2024)
- Phase I Trial of Locoregionally Delivered Autologous B7-H3 CAR T Cells in Adults with Recurrent GBM, CIRM CLIN2 Award: Lead Surgeon (PI Thomas) (November 2023 to October 2027)
- Plummer Linzy Scholarship, University of California, Davis (2000)
- Predoctoral Research Award, University of California, Davis (2001)
- Ruth L. Kirschstein National Research Service Award (PI), NIH-NCI (1F32CA132329-01) (2008-2010)
- SANS Challenge Finalist, Congress of Neurological Surgeons (2008)
- Stanford Cancer Institute Bioscience Screening Award PI, Stanford Cancer Institute (2014)
- Stanford Spectrum-Medtech Translational Grant (PI), Stanford Spectrum (2014)
- Translational Grant Co-PI, CIRM (TRAN1-08522) (2016)

View More Honors & Awards

Administrative Appointments

Assistant Program Director, Stanford University Department of Neurosurgery (2020 - Present)
Associate Dean, Academic Affairs, Stanford University School of medicine (2022 - Present)
Vice Chair of Faculty Affairs, Department of Neurosurgery, Stanford (2021 - Present)

Publications

GM-CSF mediates alveolar macrophage proliferation and type II cell hypertrophy in SP-D gene-targeted mice
Hawgood, S., Akiyama, J., Brown, C., Allen, L., Li, G., & Poulain, F. R. (2001). GM-CSF mediates alveolar macrophage proliferation and type II cell hypertrophy in SP-D gene-targeted mice. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 280(6), L1148–L1156.
Surfactant protein-A-deficient mice display an exaggerated early inflammatory response to a beta-resistant strain of influenza A virus
Li, G., Siddiqui, J., Hendry, M., Akiyama, J., Edmondson, J., Brown, C., … Hawgood, S. (2002). Surfactant protein-A-deficient mice display an exaggerated early inflammatory response to a beta-resistant strain of influenza A virus. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 26(3), 277–282.
Cerebral perfusion imaging in vasospasm.
Lad, S. P., Guzman, R., Kelly, M. E., Li, G., Lim, M., Lovbald, K., & Steinberg, G. K. (2006). Cerebral perfusion imaging in vasospasm. Neurosurgical Focus, 21(3), E7-?
- Carotid and vertebral rete mirabile in man presenting with intraparenchymal hemorrhage: a case report.
  Li, G., Jayaraman, M. V., Lad, S. P., Adler, J., Do, H., & Steinberg, G. K. (2006). Carotid and vertebral rete mirabile in man presenting with intraparenchymal hemorrhage: a case report. Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association, 15(5), 228–31.
- Intracranial hypotension from intrathecal baclofen pump insertion
  Lad, S. P., Li, G., Lin, S.-C., & Henderson, J. M. (2008). Intracranial hypotension from intrathecal baclofen pump insertion. STEREOTACTIC AND FUNCTIONAL NEUROSURGERY, 86(2), 75–79.
- CyberKnife rhizotomy for facetogenic back pain: a pilot study.
  Li, G., Patil, C., Adler, J. R., Lad, S. P., Soltys, S. G., Gibbs, I. C., … Boakye, M. (2007). CyberKnife rhizotomy for facetogenic back pain: a pilot study. Neurosurgical Focus, 23(6), E2-?
- Irradiation of glomus jugulare tumors: a historical perspective.
  Li, G., Chang, S., Adler, J. R., & Lim, M. (2007). Irradiation of glomus jugulare tumors: a historical perspective. Neurosurgical Focus, 23(6), E13-?
- CyberKnife radiosurgical rhizotomy for the treatment of atypical trigeminal nerve pain.
  Patil, C. G., Veeravagu, A., Bower, R. S., Li, G., Chang, S. D., Lim, M., & Adler, J. R. (2007). CyberKnife radiosurgical rhizotomy for the treatment of atypical trigeminal nerve pain. Neurosurgical Focus, 23(6), E9-?
- Perioperative management of ventriculoperitoneal shunts during abdominal surgery
  Li, G., & Dutta, S. (2008). Perioperative management of ventriculoperitoneal shunts during abdominal surgery. SURGICAL NEUROLOGY, 70(5), 492–97.
- Effects of age and Comorbidities on complication rates and adverse outcomes after lumbar laminectomy in elderly patients
  Li, G., Patil, C. G., Lad, S. P., Ho, C., Tian, W., & Boakye, M. (2008). Effects of age and Comorbidities on complication rates and adverse outcomes after lumbar laminectomy in elderly patients. SPINE, 33(11), 1250–55.
- EGF receptor variant III as a target antigen for tumor immunotherapy
  Li, G., & Wong, A. J. (2008). EGF receptor variant III as a target antigen for tumor immunotherapy. EXPERT REVIEW OF VACCINES, 7(7), 977–85.
- CYBERKNIFE FOR BRAIN METASTASES OF MALIGNANT MELANOMA AND RENAL CELL CARCINOMA
  Hara, W., Tran, P., Li, G., Su, Z., Puataweepong, P., Adler, J. R., … Gibbs, I. C. (2009). CYBERKNIFE FOR BRAIN METASTASES OF MALIGNANT MELANOMA AND RENAL CELL CARCINOMA. NEUROSURGERY, 64(2), A26–A32.
- Passive Antibody-Mediated Immunotherapy for the Treatment of Malignant Gliomas
  Mitra, S., Li, G., & Harsh, G. R. (2010). Passive Antibody-Mediated Immunotherapy for the Treatment of Malignant Gliomas. NEUROSURGERY CLINICS OF NORTH AMERICA, 21(1), 67-?
- The Epidermal Growth Factor Variant III Peptide Vaccine for Treatment of Malignant Gliomas
  Li, G., Mitra, S., & Wong, A. J. (2010). The Epidermal Growth Factor Variant III Peptide Vaccine for Treatment of Malignant Gliomas. NEUROSURGERY CLINICS OF NORTH AMERICA, 21(1), 87-?
- Radiosurgery for glomus jugulare: history and recent progress
  Guss, Z. D., Batra, S., Li, G., Chang, S. D., Parsa, A. T., Rigamont, D., … Lim, M. (2009). Radiosurgery for glomus jugulare: history and recent progress. NEUROSURGICAL FOCUS, 27(6).
- Pineal Parenchymal Tumor of Intermediate Differentiation: Clinicopathological Report and Analysis of Epidermal Growth Factor Receptor Variant III Expression
  Li, G., Mitra, S., Karamchandani, J., Edwards, M. S. B., & Wong, A. J. (2010). Pineal Parenchymal Tumor of Intermediate Differentiation: Clinicopathological Report and Analysis of Epidermal Growth Factor Receptor Variant III Expression. NEUROSURGERY, 66(5), 963–68.
- Development of an EGFRvIII specific recombinant antibody
  Gupta, P., Han, S.-Y., Holgado-Madruga, M., Mitra, S. S., Li, G., Nitta, R. T., & Wong, A. J. (2010). Development of an EGFRvIII specific recombinant antibody. BMC BIOTECHNOLOGY, 10.
- Hedgehog-responsive candidate cell of origin for diffuse intrinsic pontine glioma
  Monje, M., Mitra, S. S., Freret, M. E., Raveh, T. B., Kim, J., Masek, M., … Beachy, P. A. (2011). Hedgehog-responsive candidate cell of origin for diffuse intrinsic pontine glioma. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 108(11), 4453–58.
- RADIOSURGERY OF GLOMUS JUGULARE TUMORS: A META-ANALYSIS
  Guss, Z. D., Batra, S., Limb, C. J., Li, G., Sughrue, M. E., Redmond, K., … Lim, M. (2011). RADIOSURGERY OF GLOMUS JUGULARE TUMORS: A META-ANALYSIS. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 81(4), E497–E502.
- Arachnoid ossificans containing metaplastic hematopoietic marrow resulting in diffuse thoracic intrathecal cysts and severe myelopathy.
  Abrams, J., Li, G., Mindea, S. A., Haynes, C. M., & Cheng, I. (2012). Arachnoid ossificans containing metaplastic hematopoietic marrow resulting in diffuse thoracic intrathecal cysts and severe myelopathy. European Spine Journal , 21, S436–40.
- The invasive nature of glioblastoma.
  Nitta, R. T., & Li, G. (2013). The invasive nature of glioblastoma. World Neurosurgery, 80(3-4), 279–80.
- Neurosurgery concepts.
  Yang, I., Cho, J. M., Colen, C. B., Li, G., Lim, M., Sherman, J. H., & Wang, V. Y. (2011). Neurosurgery concepts. Surgical Neurology International, 2, 173-?
- Targeting EGF receptor variant III: tumor-specific peptide vaccination for malignant gliomas
  Del Vecchio, C. A., Li, G., & Wong, A. J. (2012). Targeting EGF receptor variant III: tumor-specific peptide vaccination for malignant gliomas. EXPERT REVIEW OF VACCINES, 11(2), 133–44.
- The predictive value of serum myeloperoxidase for vasospasm in patients with aneurysmal subarachnoid hemorrhage
  Lim, M., Bower, R. S., Wang, Y., Sims, L., Bower, M. R., Camara-Quintana, J., … Guccione, S. (2012). The predictive value of serum myeloperoxidase for vasospasm in patients with aneurysmal subarachnoid hemorrhage. NEUROSURGICAL REVIEW, 35(3), 413–19.
- Expression of epidermal growth factor variant III (EGFRvIII) in pediatric diffuse intrinsic pontine gliomas
  Li, G., Mitra, S. S., Monje, M., Henrich, K. N., Bangs, C. D., Nitta, R. T., & Wong, A. J. (2012). Expression of epidermal growth factor variant III (EGFRvIII) in pediatric diffuse intrinsic pontine gliomas. JOURNAL OF NEURO-ONCOLOGY, 108(3), 395–402.
- Pathology: Commonly Monitored Glioblastoma Markers: EFGR, EGFRvIII, PTEN, and MGMT
  Camara-Quintana, J. Q., Nitta, R. T., & Li, G. (2012). Pathology: Commonly Monitored Glioblastoma Markers: EFGR, EGFRvIII, PTEN, and MGMT. NEUROSURGERY CLINICS OF NORTH AMERICA, 23(2), 237-?
- The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors
  Willingham, S. B., Volkmer, J.-P., Gentles, A. J., Sahoo, D., Dalerba, P., Mitra, S. S., … Weissman, I. L. (2012). The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 109(17), 6662–67.
- Perspectives on key articles in neurosurgery.
  Lim, M., Sherman, J. H., Wang, V. Y., Smith, Z. A., Cho, J. M., Colen, C. B., … Yang, I. (2012). Perspectives on key articles in neurosurgery. Surgical Neurology International, 3, 58-?
- The incidence and significance of multiple lesions in glioblastoma
  Thomas, R. P., Xu, L. W., Lober, R. M., Li, G., & Nagpal, S. (2013). The incidence and significance of multiple lesions in glioblastoma. JOURNAL OF NEURO-ONCOLOGY, 112(1), 91–97.
- Neurosurgery concepts: Key perspectives on regulatory proteins, management of ossification of the posterior longitudinal ligament, and radiosurgery for intracranial lesions.
  Sherman, J. H., Smith, Z. A., Cho, J. M., Lim, M., Colen, C. B., Kim, C.-Y., … Yang, I. (2013). Neurosurgery concepts: Key perspectives on regulatory proteins, management of ossification of the posterior longitudinal ligament, and radiosurgery for intracranial lesions. Surgical Neurology International, 4, 35-?
- GLIOBLASTOMA CELLS EXPRESSING EGFRVIII ARE MORE SENSITIVE TO CK2 INHIBITION
  Nitta, R., Mitra, S., Bui, T., & Li, G. (2012). GLIOBLASTOMA CELLS EXPRESSING EGFRVIII ARE MORE SENSITIVE TO CK2 INHIBITION. Presented at the 17th Annual Scientific Meeting and Education Day of the Society-for-Neuro-Oncology (SNO), WASHINGTON,DC: OXFORD UNIV PRESS INC.
- Robotic radiosurgery for the treatment of radioresistant brain metastases
  Hara, W., Li, G., Puataweepong, P., Adler, J., Chang, S., & Gibbs, I. C. (2006). Robotic radiosurgery for the treatment of radioresistant brain metastases. NEURO-ONCOLOGY, 8(4), 486–486.
- Radiosurgery of Glomus Jugulare Tumors: A Meta-analysis
  Guss, Z. D., Batra, S., Li, G., Chang, S. D., Parsa, A. T., Rigamonti, D., … Lim, M. (2010). Radiosurgery of Glomus Jugulare Tumors: A Meta-analysis. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 78(3), S288–S289.
- Risk of Leptomeningeal Disease in Patients Treated With Stereotactic Radiosurgery Targeting the Postoperative Resection Cavity for Brain Metastases
  Atalar, B., Modlin, L. A., Choi, C. Y. H., Adler, J. R., Gibbs, I. C., Chang, S. D., … Soltys, S. G. (2013). Risk of Leptomeningeal Disease in Patients Treated With Stereotactic Radiosurgery Targeting the Postoperative Resection Cavity for Brain Metastases. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 87(4), 713–718.
- Multi-institutional validation of a preoperative scoring system which predicts survival for patients with glioblastoma.
  Chaichana, K. L., Pendleton, C., Chambless, L., Camara-Quintana, J., Nathan, J. K., Hassam-Malani, L., … Quinones-Hinojosa, A. (2013). Multi-institutional validation of a preoperative scoring system which predicts survival for patients with glioblastoma. Journal of Clinical Neuroscience , 20(10), 1422–26.
- Targeting a Glioblastoma Cancer Stem-Cell Population Defined by EGF Receptor Variant III.
  Emlet, D. R., Gupta, P., Holgado-Madruga, M., Del Vecchio, C. A., Mitra, S. S., Han, S.-Y., … Wong, A. J. (2014). Targeting a Glioblastoma Cancer Stem-Cell Population Defined by EGF Receptor Variant III. Cancer Research, 74(4), 1238–49.
- Current Vaccine Trials in Glioblastoma: A Review
  Xu, L. W., Chow, K. K., Lim, M., & Li, G. (2014). Current Vaccine Trials in Glioblastoma: A Review. JOURNAL OF IMMUNOLOGY RESEARCH.
- The Combined Subtemporal-Transfacial Approach for the Resection of Juvenile Nasopharyngeal Angiofibromas With Intracranial Extension
  Kumar, A. R., Nayak, J. V., Janisiewicz, A. M., Li, G., & Oghalai, J. S. (2015). The Combined Subtemporal-Transfacial Approach for the Resection of Juvenile Nasopharyngeal Angiofibromas With Intracranial Extension. OTOLOGY & NEUROTOLOGY, 36(1), 151–55.
- Casein kinase 2a regulates glioblastoma brain tumor-initiating cell growth through the ß-catenin pathway.
  Nitta, R. T., Gholamin, S., Feroze, A. H., Agarwal, M., Cheshier, S. H., Mitra, S. S., & Li, G. (2015). Casein kinase 2a regulates glioblastoma brain tumor-initiating cell growth through the ß-catenin pathway. Oncogene, 34(28), 3688–99.
- The future of glioblastoma therapy: synergism of standard of care and immunotherapy.
  Patel, M. A., Kim, J. E., Ruzevick, J., Li, G., & Lim, M. (2014). The future of glioblastoma therapy: synergism of standard of care and immunotherapy. Cancers, 6(4), 1953–85.
- Casein Kinase 2: a novel player in glioblastoma therapy and cancer stem cells.
  Agarwal, M., Nitta, R. T., & Li, G. (2013). Casein Kinase 2: a novel player in glioblastoma therapy and cancer stem cells. Journal of Molecular and Genetic Medicine : an International Journal of Biomedical Research, 8(1).
- Pilocytic astrocytoma with IDH1 mutation in the cerebellum of an elderly patient.
  Medress, Z. A., Xu, L. W., Ziskin, J. L., Lefterova, M., Vogel, H., & Li, G. (2014). Pilocytic astrocytoma with IDH1 mutation in the cerebellum of an elderly patient. Clinical Neuropathology.
- Atypical and rare variants of central neurocytomas.
  Choudhri, O., Razavi, S.-M., Vogel, H., & Li, G. (2015). Atypical and rare variants of central neurocytomas. Neurosurgery Clinics of North America, 26(1), 91–98.
- Intracranial fat migration: A newly described complication of autologous fat repair of a cerebrospinal fluid leak following supracerebellar infratentorial approach.
  Ludwig, C. A., Aujla, P., Moreno, M., Veeravagu, A., & Li, G. (2015). Intracranial fat migration: A newly described complication of autologous fat repair of a cerebrospinal fluid leak following supracerebellar infratentorial approach. International Journal of Surgery Case Reports, 7C, 1–5.
- Neurosurgery concepts: Key perspectives on dendritic cell vaccines, metastatic tumor treatment, and radiosurgery.
  Li, G., Sherman, J. H., Cho, J. M., Lim, M., Khalessi, A. A., Colen, C. B., … Yang, I. (2015). Neurosurgery concepts: Key perspectives on dendritic cell vaccines, metastatic tumor treatment, and radiosurgery. Surgical Neurology International, 6, 6.
- Preoperative endovascular embolization of meningiomas: update on therapeutic options
  Shah, A., Choudhri, O., Jung, H., & Li, G. (2015). Preoperative endovascular embolization of meningiomas: update on therapeutic options. NEUROSURGICAL FOCUS, 38(3).
- Combining immunotherapy with radiation for the treatment of glioblastoma.
  Chow, K. K., Hara, W., Lim, M., & Li, G. (2015). Combining immunotherapy with radiation for the treatment of glioblastoma. Journal of Neuro-Oncology, 123(3), 459–64.
- Phase II pilot study of single-agent etirinotecan pegol (NKTR-102) in bevacizumab-resistant high grade glioma
  Nagpal, S., Recht, C. K., Bertrand, S., Thomas, R. P., Ajlan, A., Pena, J., … Recht, L. D. (2015). Phase II pilot study of single-agent etirinotecan pegol (NKTR-102) in bevacizumab-resistant high grade glioma. JOURNAL OF NEURO-ONCOLOGY, 123(2), 277–82.
- Glioblastoma Multiforme Recurrence: An Exploratory Study of F-18 FPPRGD(2) PET/CT1
  Iagaru, A., Mosci, C., Mittra, E., Zaharchuk, G., Fischbein, N., Harsh, G., … Gambhir, S. S. (2015). Glioblastoma Multiforme Recurrence: An Exploratory Study of F-18 FPPRGD(2) PET/CT1. RADIOLOGY, 277(2), 497–506.
- Glioblastoma antigen discovery--foundations for immunotherapy.
  Azad, T. D., Razavi, S.-M., Jin, B., Lee, K., & Li, G. (2015). Glioblastoma antigen discovery--foundations for immunotherapy. Journal of Neuro-Oncology, 123(3), 347–58.
- Neurosurgery Concepts: Key perspectives on Traumatic Brain Injury, New Treatments for Glioblastoma, Hemicraniectomy for Extensive Middle-Cerebral-Artery Stroke, Minimally Invasive Spine Surgery and Lumbar Epidural Injections for Radiculopathy.
  Cho, J. M., Colen, C. B., Li, G., Wang, V. Y., Dahdaleh, N., Choy, W., … Smith, Z. A. (2015). Neurosurgery Concepts: Key perspectives on Traumatic Brain Injury, New Treatments for Glioblastoma, Hemicraniectomy for Extensive Middle-Cerebral-Artery Stroke, Minimally Invasive Spine Surgery and Lumbar Epidural Injections for Radiculopathy. Surgical Neurology International, 6, 98.
- Neurosurgery Concepts: Key perspectives on quality of life in children with spina bifida, cilengitide for the treatment of newly diagnosed glioblastoma, surgery and stereotactic radiosurgery in the management of intracranial metastasis, Gamma Knife radiosurgery in patients with Neurofibromatosis Type 2, patient misconceptions on the diagnosis and treatment of lumbar spondylosis.
  Lam, S., Li, G., Zada, G., Pelargos, P., Choy, W., Yang, I., & Smith, Z. A. (2015). Neurosurgery Concepts: Key perspectives on quality of life in children with spina bifida, cilengitide for the treatment of newly diagnosed glioblastoma, surgery and stereotactic radiosurgery in the management of intracranial metastasis, Gamma Knife radiosurgery in patients with Neurofibromatosis Type 2, patient misconceptions on the diagnosis and treatment of lumbar spondylosis. Surgical Neurology International, 6, 110.
- Dual-trajectory Approach for Simultaneous Cyst Fenestration and Endoscopic Third Ventriculostomy for Treatment of a Complex Third Ventricular Arachnoid Cyst.
  Ho, A. L., Pendharkar, A. V., Sussman, E. S., Ravikumar, V. K., & Li, G. H. (2015). Dual-trajectory Approach for Simultaneous Cyst Fenestration and Endoscopic Third Ventriculostomy for Treatment of a Complex Third Ventricular Arachnoid Cyst. Cureus, 7(3).
- 107 ReACT: Overall Survival From a Randomized Phase II Study of Rindopepimut (CDX-110) Plus Bevacizumab in Relapsed Glioblastoma.
  Reardon, D. A., Schuster, J. M., Tran, D. D., Fink, K. L., Nabors, L. B., Li, G., … Sampson, J. H. (2015). 107 ReACT: Overall Survival From a Randomized Phase II Study of Rindopepimut (CDX-110) Plus Bevacizumab in Relapsed Glioblastoma. Neurosurgery, 62 Suppl 1, CLINICAL NEUROSURGERY, 198–199.
- Repeat Courses of Stereotactic Radiosurgery (SRS), Deferring Whole-Brain Irradiation, for New Brain Metastases After Initial SRS
  Shultz, D. B., Modlin, L. A., Jayachandran, P., von Eyben, R., Gibbs, I. C., Choi, C. Y. H., … Soltys, S. G. (2015). Repeat Courses of Stereotactic Radiosurgery (SRS), Deferring Whole-Brain Irradiation, for New Brain Metastases After Initial SRS. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 92(5), 993–99.
- Craniotomy for Resection of Meningioma: An Age-Stratified Analysis of the MarketScan Longitudinal Database
  Connolly, I. D., Cole, T., Veeravagu, A., Popat, R., Ratliff, J., & Li, G. (2015). Craniotomy for Resection of Meningioma: An Age-Stratified Analysis of the MarketScan Longitudinal Database. WORLD NEUROSURGERY, 84(6), 1864–70.
- Intracranial Dislocation of the Mandibular Condyle: A Case Report and Literature Review
  Zhang, M., Alexander, A. L., Most, S. P., Li, G., & Harris, O. A. (2016). Intracranial Dislocation of the Mandibular Condyle: A Case Report and Literature Review. WORLD NEUROSURGERY, 86.
- gamma-Glutamyl transferase 7 is a novel regulator of glioblastoma growth
  Bui, T. T., Nitta, R. T., Kahn, S. A., Razavi, S.-M., Agarwal, M., Aujla, P., … Li, G. (2015). gamma-Glutamyl transferase 7 is a novel regulator of glioblastoma growth. BMC CANCER, 15.
- Retrosigmoid Versus Translabyrinthine Approach for Acoustic Neuroma Resection: An Assessment of Complications and Payments in a Longitudinal Administrative Database.
  Cole, T., Veeravagu, A., Zhang, M., Azad, T., Swinney, C., Li, G. H., … Giannotta, S. L. (2015). Retrosigmoid Versus Translabyrinthine Approach for Acoustic Neuroma Resection: An Assessment of Complications and Payments in a Longitudinal Administrative Database. Cure¯Us, 7(10).
- Purification and Characterization of Progenitor and Mature Human Astrocytes Reveals Transcriptional and Functional Differences with Mouse
  Zhang, Y., Sloan, S. A., Clarke, L. E., Caneda, C., Plaza, C. A., Blumenthal, P. D., … Barres, B. A. (2016). Purification and Characterization of Progenitor and Mature Human Astrocytes Reveals Transcriptional and Functional Differences with Mouse. NEURON, 89(1), 37–53.
- Key perspectives on donepezil following brain irradiation, sacroiliac joint fusion, indocyanine green fluorescence endoscope in endonasal transsphenoidal surgery, postconcussion syndrome in young athletes.
  Li, G., Dahdaleh, N. S., Germanwala, A. V., Lam, S., Choy, W., Smith, Z. A., & Yang, I. (2015). Key perspectives on donepezil following brain irradiation, sacroiliac joint fusion, indocyanine green fluorescence endoscope in endonasal transsphenoidal surgery, postconcussion syndrome in young athletes. Surgical Neurology International, 6(Suppl 26), S647–50.
- New tools for studying microglia in the mouse and human CNS.
  Bennett, M. L., Bennett, F. C., Liddelow, S. A., Ajami, B., Zamanian, J. L., Fernhoff, N. B., … Barres, B. A. (2016). New tools for studying microglia in the mouse and human CNS. Proceedings of the National Academy of Sciences of the United States of America, 113(12), E1738–46.
- Endovascular therapies for malignant gliomas: Challenges and the future
  Su, Y. R. S., Ali, R., Feroze, A. H., Li, G., Lawton, M. T., & Choudhri, O. (2016). Endovascular therapies for malignant gliomas: Challenges and the future. JOURNAL OF CLINICAL NEUROSCIENCE, 26, 26–32.
- Atypical and Rare Variants of Central Neurocytomas
  Choudhri, O., Razavi, S.-M., Vogel, H., & Li, G. (2015). Atypical and Rare Variants of Central Neurocytomas. NEUROSURGERY CLINICS OF NORTH AMERICA, 26(1), 91-?
- Immune Evasion Strategies of Glioblastoma.
  Razavi, S.-M., Lee, K. E., Jin, B. E., Aujla, P. S., Gholamin, S., & Li, G. (2016). Immune Evasion Strategies of Glioblastoma. Frontiers in Surgery, 3, 11-?
- Dose-Response Modeling of the Visual Pathway Tolerance to Single-Fraction and Hypofractionated Stereotactic Radiosurgery
  Hiniker, S. M., Modlin, L. A., Choi, C. Y., Atalar, B., Seiger, K., Binkley, M. S., … Soltys, S. G. (2016). Dose-Response Modeling of the Visual Pathway Tolerance to Single-Fraction and Hypofractionated Stereotactic Radiosurgery. SEMINARS IN RADIATION ONCOLOGY, 26(2), 97–104.
- Frameless, electromagnetic image-guided ventriculostomy for ventriculoperitoneal shunt and Ommaya reservoir placement
  Xu, L. W., Sussman, E. S., & Li, G. (2016). Frameless, electromagnetic image-guided ventriculostomy for ventriculoperitoneal shunt and Ommaya reservoir placement. CLINICAL NEUROLOGY AND NEUROSURGERY, 147, 46–52.
- Glioblastoma Multiforme Recurrence: An Exploratory Study of (18)F FPPRGD2 PET/CT.
  Iagaru, A., Mosci, C., Mittra, E., Zaharchuk, G., Fischbein, N., Harsh, G., … Gambhir, S. S. (2016). Glioblastoma Multiforme Recurrence: An Exploratory Study of (18)F FPPRGD2 PET/CT. Radiology, 280(1), 328-?
- Key perspectives on auditory outcomes following radiosurgery for vestibular schwannoma, tumor treating fields for glioblastoma, and a proposed myelopathy score for cervical decompression surgery, intracranial pressure monitoring in diffuse traumatic brain injury.
  Sherman, J. H., Li, G., Cho, J. M., Choy, W., Yang, I., & Smith, Z. A. (2016). Key perspectives on auditory outcomes following radiosurgery for vestibular schwannoma, tumor treating fields for glioblastoma, and a proposed myelopathy score for cervical decompression surgery, intracranial pressure monitoring in diffuse traumatic brain injury. Surgical Neurology International, 7(Suppl 27), S725–S728.
- Magnetic Resonance-Guided Laser-Induced Thermal Therapy for Recurrent Brain Metastases in the Motor Strip After Stereotactic Radiosurgery.
  Iyer, A., Halpern, C. H., Grant, G. A., Deb, S., & Li, G. H. (2016). Magnetic Resonance-Guided Laser-Induced Thermal Therapy for Recurrent Brain Metastases in the Motor Strip After Stereotactic Radiosurgery. Cureus, 8(12).
- Neurosurgery concepts: Key perspectives on imaging characteristics of spinal metastases, surgery for low back pain, anesthesia for disc surgery, and laminectomy versus laminectomy and fusion for lumbar spondylolisthesis.
  Lagman, C., Chung, L. K., Macyszyn, L., Choy, W., Smith, Z. A., Dahdaleh, N. S., … Yang, I. (2017). Neurosurgery concepts: Key perspectives on imaging characteristics of spinal metastases, surgery for low back pain, anesthesia for disc surgery, and laminectomy versus laminectomy and fusion for lumbar spondylolisthesis. Surgical Neurology International, 8, 9.
- Cranioplasty Complications and Costs: A National Population-Level Analysis Using the MarketScan Longitudinal Database.
  Li, A., Azad, T. D., Veeravagu, A., Bhatti, I., Long, C., Ratliff, J. K., & Li, G. (2017). Cranioplasty Complications and Costs: A National Population-Level Analysis Using the MarketScan Longitudinal Database. World Neurosurgery, 102, 209–20.
- The Use of Vancomycin Powder for Surgical Prophylaxis Following Craniotomy.
  Ravikumar, V., Ho, A. L., Pendhakar, A. V., Sussman, E. S., Kwong-Hon Chow, K., & Li, G. (2017). The Use of Vancomycin Powder for Surgical Prophylaxis Following Craniotomy. Neurosurgery, 80(5), 754–58.
- Neurosurgery concepts: Key perspectives on endoscopic versus microscopic resection for pituitary adenomas, surgical decision-making in tuberculum sellae meningiomas, optic nerve mobilization during resection of craniopharyngiomas, and evaluation of headache and quality of life after endoscopic transphenoidal surgery for pituitary adenomas.
  Germanwala, A. V., Hofler, R., Lagman, C., Chung, L. K., Khalessi, A. A., Zada, G., … Yang, I. (2017). Neurosurgery concepts: Key perspectives on endoscopic versus microscopic resection for pituitary adenomas, surgical decision-making in tuberculum sellae meningiomas, optic nerve mobilization during resection of craniopharyngiomas, and evaluation of headache and quality of life after endoscopic transphenoidal surgery for pituitary adenomas. Surgical Neurology International, 8, 52.
- History and current state of immunotherapy in glioma and brain metastasis
  McGranahan, T., Li, G., & Nagpal, S. (2017). History and current state of immunotherapy in glioma and brain metastasis. THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 9(5), 347–68.
- Phase 1/2 Trial of 5-Fraction Stereotactic Radiosurgery With 5-mm Margins With Concurrent and Adjuvant Temozolomide in Newly Diagnosed Supratentorial Glioblastoma: Health-Related Quality of Life Results.
  Pollom, E. L., Fujimoto, D., Wynne, J., Seiger, K., Modlin, L. A., Jacobs, L. R., … Soltys, S. G. (2017). Phase 1/2 Trial of 5-Fraction Stereotactic Radiosurgery With 5-mm Margins With Concurrent and Adjuvant Temozolomide in Newly Diagnosed Supratentorial Glioblastoma: Health-Related Quality of Life Results. International Journal of Radiation Oncology, Biology, Physics, 98(1), 123–30.
- Stereotactic Radiosurgery and Hypofractionated Radiotherapy for Glioblastoma.
  Shah, J. L., Li, G., Shaffer, J. L., Azoulay, M. I., Gibbs, I. C., Nagpal, S., & Soltys, S. G. (2017). Stereotactic Radiosurgery and Hypofractionated Radiotherapy for Glioblastoma. Neurosurgery.
- Microsurgical vs. Endoscopic Excision of Colloid Cysts: An Analysis of Complications and Costs Using a Longitudinal Administrative Database.
  Connolly, I. D., Johnson, E., Lamsam, L., Veeravagu, A., Ratliff, J., & Li, G. (2017). Microsurgical vs. Endoscopic Excision of Colloid Cysts: An Analysis of Complications and Costs Using a Longitudinal Administrative Database. Frontiers in Neurology, 8, 259.
- The Future of Glioblastoma Therapy: Synergism of Standard of Care and Immunotherapy
  Patel, M. A., Kim, J. E., Ruzevick, J., Li, G., & Lim, M. (2014). The Future of Glioblastoma Therapy: Synergism of Standard of Care and Immunotherapy. CANCERS, 6(4), 1953–85.
- Endoscopic vs. Microscopic Resection of Sellar Lesions-A Matched Analysis of Clinical and Socioeconomic Outcomes.
  Azad, T. D., Lee, Y.-J. J., Vail, D., Veeravagu, A., Hwang, P. H., Ratliff, J. K., & Li, G. (2017). Endoscopic vs. Microscopic Resection of Sellar Lesions-A Matched Analysis of Clinical and Socioeconomic Outcomes. Frontiers in Surgery, 4, 33.
- Comparison of porcine and bovine collagen dural substitutes in posterior fossa decompression for Chiari I malformation in adults.
  Lee, C. K., Mokhtari, T., Connolly, I. D., Li, G., Shuer, L. M., Chang, S. D., … Gephart, M. H. (2017). Comparison of porcine and bovine collagen dural substitutes in posterior fossa decompression for Chiari I malformation in adults. World Neurosurgery.
- Single-Cell RNA-Seq Analysis of Infiltrating Neoplastic Cells at the Migrating Front of Human Glioblastoma.
  Darmanis, S., Sloan, S. A., Croote, D., Mignardi, M., Chernikova, S., Samghababi, P., … Quake, S. R. (2017). Single-Cell RNA-Seq Analysis of Infiltrating Neoplastic Cells at the Migrating Front of Human Glioblastoma. Cell Reports, 21(5), 1399–1410.
- Imaging changes over 18 months following stereotactic radiosurgery for brain metastases: both late radiation necrosis and tumor progression can occur.
  Fujimoto, D., von Eyben, R., Gibbs, I. C., Chang, S. D., Li, G., Harsh, G. R., … Soltys, S. G. (2017). Imaging changes over 18 months following stereotactic radiosurgery for brain metastases: both late radiation necrosis and tumor progression can occur. Journal of Neuro-Oncology.
- First-in-human intraoperative near-infrared fluorescence imaging of glioblastoma using cetuximab-IRDye800.
  Miller, S. E., Tummers, W. S., Teraphongphom, N., van den Berg, N. S., Hasan, A., Ertsey, R. D., … Rosenthal, E. L. (2018). First-in-human intraoperative near-infrared fluorescence imaging of glioblastoma using cetuximab-IRDye800. Journal of Neuro-Oncology.
- THE INCIDENCE AND SIGNIFICANCE OF MULTIPLE LESIONS IN GLIOBLASTOMA
  Xu, L. W., Thomas, R. P., Lober, R. M., Nagpal, S., & Li, G. (2012). THE INCIDENCE AND SIGNIFICANCE OF MULTIPLE LESIONS IN GLIOBLASTOMA. NEURO-ONCOLOGY. OXFORD UNIV PRESS INC.
- In Reply: The Use of Vancomycin Powder for Surgical Prophylaxis Following Craniotomy
  Ho, A. L., & Li, G. H. (2018). In Reply: The Use of Vancomycin Powder for Surgical Prophylaxis Following Craniotomy. NEUROSURGERY, 82(2), E71.
- Multiple Extradural Spinal Meningiomas in a Patient with Acquired Immunodeficiency Syndrome: Case Report and Literature Review.
  Ghanchi, H., Hariri, O. R., Takayanagi, A., & Li, G. (2018). Multiple Extradural Spinal Meningiomas in a Patient with Acquired Immunodeficiency Syndrome: Case Report and Literature Review. World Neurosurgery.
- Osimertinib for EGFR-Mutant Lung Cancer with Brain Metastases: Results from a Single-Center Retrospective Study.
  Xie, L., Nagpal, S., Wakelee, H. A., Li, G., Soltys, S. G., & Neal, J. W. (2018). Osimertinib for EGFR-Mutant Lung Cancer with Brain Metastases: Results from a Single-Center Retrospective Study. The Oncologist.
- Topical vancomycin surgical prophylaxis in pediatric open craniotomies: an institutional experience.
  Ho, A. L., Cannon, J. G., Mohole, J., Pendharkar, A. V., Sussman, E. S., Li, G., … Grant, G. A. (2018). Topical vancomycin surgical prophylaxis in pediatric open craniotomies: an institutional experience. Journal of Neurosurgery. Pediatrics, 1–6.
- ReACT: A PHASE II STUDY OF RINDOPEPIMUT VACCINE (CDX-110) PLUS BEVACIZUMAB IN RELAPSED GLIOBLASTOMA
  Reardon, D., Schuster, J., Tran, D., Fink, K., Nabors, L., Li, G., … Sampson, J. (2014). ReACT: A PHASE II STUDY OF RINDOPEPIMUT VACCINE (CDX-110) PLUS BEVACIZUMAB IN RELAPSED GLIOBLASTOMA. NEURO-ONCOLOGY. OXFORD UNIV PRESS INC.
- ReACT: A PHASE II STUDYOF RINDOPEPIMUT VACCINE (CDX-110) PLUS BEVACIZUMAB IN RELAPSED GLIOBLASTOMA
  Reardon, D., Li, G., Recht, L., Fink, K., Nabors, L., Tran, D., … Sampson, J. (2013). ReACT: A PHASE II STUDYOF RINDOPEPIMUT VACCINE (CDX-110) PLUS BEVACIZUMAB IN RELAPSED GLIOBLASTOMA. NEURO-ONCOLOGY. OXFORD UNIV PRESS INC.
- Developmental phosphoproteomics identifies the kinase CK2 as a driver of Hedgehog signaling and a therapeutic target in medulloblastoma.
  Purzner, T., Purzner, J., Buckstaff, T., Cozza, G., Gholamin, S., Rusert, J. M., … Scott, M. P. (2018). Developmental phosphoproteomics identifies the kinase CK2 as a driver of Hedgehog signaling and a therapeutic target in medulloblastoma. Science Signaling, 11(547).
- How Intraoperative Tools and Techniques Have Changed the Approach to Brain Tumor Surgery.
  Fatemi, P., Zhang, M., Miller, K. J., Robe, P., & Li, G. (2018). How Intraoperative Tools and Techniques Have Changed the Approach to Brain Tumor Surgery. Current Oncology Reports, 20(11), 89.
- Notch1 regulates the initiation of metastasis and self-renewal of Group 3 medulloblastoma.
  Kahn, S. A., Wang, X., Nitta, R. T., Gholamin, S., Theruvath, J., Hutter, G., … Cheshier, S. H. (2018). Notch1 regulates the initiation of metastasis and self-renewal of Group 3 medulloblastoma. Nature Communications, 9(1), 4121.
- First In-Human Intraoperative Near-Infrared Fluorescence Imaging of Glioblastoma Using Cetuximab-IRDye800: Results from a Pilot Study
  Miller, S. E., Tummers, W. S., (Tarn) Teraphongphom, N., Hasan, A. J., Ertsey, R. D., Harsh, G. R., … Rosenthal, E. L. (2017). First In-Human Intraoperative Near-Infrared Fluorescence Imaging of Glioblastoma Using Cetuximab-IRDye800: Results from a Pilot Study. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS. ELSEVIER SCIENCE INC.
- Quantification of Macrophages in High-Grade Gliomas by Using Ferumoxytol-enhanced MRI: A Pilot Study.
  Iv, M., Samghabadi, P., Holdsworth, S., Gentles, A., Rezaii, P., Harsh, G., … Yeom, K. W. (2018). Quantification of Macrophages in High-Grade Gliomas by Using Ferumoxytol-enhanced MRI: A Pilot Study. Radiology, 181204.
- Defining and targeting a Glioblastoma cancer stem cell population with EGF Receptor Variant III.
  Emlet, D. R., Del Vecchio, C., Gupta, P., Mitra, S., Han, S.-Y., Holgado-Madruga, M., … Wong, A. J. (2013). Defining and targeting a Glioblastoma cancer stem cell population with EGF Receptor Variant III. CANCER RESEARCH. AMER ASSOC CANCER RESEARCH.
- Publisher Correction: Notch1 regulates the initiation of metastasis and self-renewal of Group 3 medulloblastoma.
  Kahn, S. A., Wang, X., Nitta, R. T., Gholamin, S., Theruvath, J., Hutter, G., … Cheshier, S. H. (2018). Publisher Correction: Notch1 regulates the initiation of metastasis and self-renewal of Group 3 medulloblastoma. Nature Communications, 9(1), 4651.
- Long-Term Update of Stereotactic Radiosurgery for Benign Spinal Tumors.
  Chin, A. L., Fujimoto, D., Kumar, K. A., Tupper, L., Mansour, S., Chang, S. D., … Soltys, S. G. (2018). Long-Term Update of Stereotactic Radiosurgery for Benign Spinal Tumors. Neurosurgery.
- Clinical factors associated with mortality within three months after radiosurgery of asymptomatic brain metastases from non-small cell lung cancer.
  Kakusa, B., Han, S., Aggarwal, S., Liu, B., Li, G., Soltys, S., & Hayden Gephart, M. (2018). Clinical factors associated with mortality within three months after radiosurgery of asymptomatic brain metastases from non-small cell lung cancer. Journal of Neuro-Oncology.
- TREATMENT WITH THE CASEIN KINASE 2 INHIBITOR, CX-4945, SENSITIZES MEDULLOBLASTOMA TO TEMOZOLOMIDE
  Nitta, R., & Li, G. (2018). TREATMENT WITH THE CASEIN KINASE 2 INHIBITOR, CX-4945, SENSITIZES MEDULLOBLASTOMA TO TEMOZOLOMIDE. NEURO-ONCOLOGY, 20, 52–53.
- NOTCH1 PROMOTES GROUP 3 MEDULLOBLASTOMA METASTASIS, INITIATION AND SELF-RENEWAL
  Kahn, S. A., Wang, X., Nitta, R., Gholamin, S., Ramaswamy, V., Azad, T., … Cheshier, S. (2016). NOTCH1 PROMOTES GROUP 3 MEDULLOBLASTOMA METASTASIS, INITIATION AND SELF-RENEWAL. NEURO-ONCOLOGY. OXFORD UNIV PRESS INC.
- Etirinotecan pegol (EP, NKTR-102) in the treatment of high-grade glioma (HGG): A phase 2 trial.
  Nagpal, S., Recht, C. K., Imtiaz, U., Bertrand, S., Thomas, B. P., Ajlan, A., … Recht, L. D. (2014). Etirinotecan pegol (EP, NKTR-102) in the treatment of high-grade glioma (HGG): A phase 2 trial. JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY.
- EGFRvIII EXPRESSION CONTRIBUTES TO GLIOBLASTOMA STEM CELL PROPERTIES AND ITS EXPRESSION IS REGULATED BY EPIGENETIC MECHANISMS
  Emlet, D., Del Vecchio, C., Gupta, P., Li, G., Skirboll, S., & Wong, A. (2013). EGFRvIII EXPRESSION CONTRIBUTES TO GLIOBLASTOMA STEM CELL PROPERTIES AND ITS EXPRESSION IS REGULATED BY EPIGENETIC MECHANISMS. NEURO-ONCOLOGY. OXFORD UNIV PRESS INC.
- A HIGHLY SENSITIVE, ONE-STEP QUANTITATIVE RT-PCR METHOD FOR THE DETECTION OF EGFRVIII
  Li, G., & Wong, A. (2008). A HIGHLY SENSITIVE, ONE-STEP QUANTITATIVE RT-PCR METHOD FOR THE DETECTION OF EGFRVIII. NEURO-ONCOLOGY. OXFORD UNIV PRESS INC.
- A COMBINATORIAL TREATMENT USING A CK2 INHIBITOR, CX-4945, AND TMZ DECREASED MEDULLOBLASTOMA TUMORIGENESIS
  Nitta, R., Nwagbo, G., Jin, B., & Li, G. (2017). A COMBINATORIAL TREATMENT USING A CK2 INHIBITOR, CX-4945, AND TMZ DECREASED MEDULLOBLASTOMA TUMORIGENESIS. NEURO-ONCOLOGY. OXFORD UNIV PRESS INC.
- CASEIN KINASE 2 IS A MAJOR REGULATOR OF MEDULLOBLASTOMA GROWTH AND METASTASIS
  Li, G., Nwagbo, G., & Nitta, R. (2016). CASEIN KINASE 2 IS A MAJOR REGULATOR OF MEDULLOBLASTOMA GROWTH AND METASTASIS. NEURO-ONCOLOGY. OXFORD UNIV PRESS INC.
- Lumboperitoneal and Ventriculoperitoneal Shunting for Idiopathic Intracranial Hypertension Demonstrate Comparable Failure and Complication Rates.
  Azad, T. D., Zhang, Y., Varshneya, K., Veeravagu, A., Ratliff, J. K., & Li, G. (2019). Lumboperitoneal and Ventriculoperitoneal Shunting for Idiopathic Intracranial Hypertension Demonstrate Comparable Failure and Complication Rates. Neurosurgery.
- Facial Nerve Paralysis Occurring 4 Days following Stereotactic Radiosurgery for a Vestibular Schwannoma.
  Chow, K. K.-H., Ajlan, A., Ho, A. L., Li, G., & Soltys, S. G. Facial Nerve Paralysis Occurring 4 Days following Stereotactic Radiosurgery for a Vestibular Schwannoma. Asian Journal of Neurosurgery, 14(1), 262–65.
- Glioblastoma Multiforme Recurrence: An Exploratory Study of (18)F FPPRGD2 PET/CT.
  Iagaru, A., Mosci, C., Mittra, E., Zaharchuk, G., Fischbein, N., Harsh, G., … Gambhir, S. S. (2015). Glioblastoma Multiforme Recurrence: An Exploratory Study of (18)F FPPRGD2 PET/CT. Radiology, 141550.
- Dose-Response Modeling of the Visual Pathway Tolerance to Single-Fraction and Hypofractionated Stereotactic Radiosurgery.
  Hiniker, S. M., Modlin, L. A., Choi, C. Y., Atalar, B., Seiger, K., Binkley, M. S., … Soltys, S. G. (2016). Dose-Response Modeling of the Visual Pathway Tolerance to Single-Fraction and Hypofractionated Stereotactic Radiosurgery. Seminars in Radiation Oncology, 26(2), 97–104.
- Endovascular therapies for malignant gliomas: Challenges and the future.
  Su, Y. R. S., Ali, R., Feroze, A. H., Li, G., Lawton, M. T., & Choudhri, O. (2016). Endovascular therapies for malignant gliomas: Challenges and the future. Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia, 26, 26–32.
- Quantification of Macrophages in High-Grade Gliomas by Using Ferumoxytol-enhanced MRI: A Pilot Study
  Iv, M., Samghabadi, P., Holdsworth, S., Gentles, A., Rezaii, P., Harsh, G., … Yeom, K. W. (2019). Quantification of Macrophages in High-Grade Gliomas by Using Ferumoxytol-enhanced MRI: A Pilot Study. RADIOLOGY, 290(1), 198–206.
- First-in-human intraoperative near-infrared fluorescence imaging of glioblastoma using cetuximab-IRDye800
  Miller, S. E., Tummers, W. S., Teraphongphom, N., van den Berg, N. S., Hasan, A., Ertsey, R. D., … Rosenthal, E. L. (2018). First-in-human intraoperative near-infrared fluorescence imaging of glioblastoma using cetuximab-IRDye800. JOURNAL OF NEURO-ONCOLOGY, 139(1), 135–43.
- How Intraoperative Tools and Techniques Have Changed the Approach to Brain Tumor Surgery
  Fatemi, P., Zhang, M., Miller, K. J., Robe, P., & Li, G. (2018). How Intraoperative Tools and Techniques Have Changed the Approach to Brain Tumor Surgery. CURRENT ONCOLOGY REPORTS, 20(11).
- Casein kinase 2 is a major regulator of medulloblastoma growth
  Nitta, R., Bolin, S. M., Nwagbo, G., Purzner, T., Kahn, S., Cho, Y.-J., & Li, G. (2018). Casein kinase 2 is a major regulator of medulloblastoma growth. CANCER RESEARCH, 78(13).
- Use of Diffusion Tensor Imaging in the Resection of Gliomas
  Jung, H., Shah, A., & Li, G. (2014). Use of Diffusion Tensor Imaging in the Resection of Gliomas. CURRENT SURGERY REPORTS, 2(10).
- Adverse Radiation Effect and Disease Control in Patients Undergoing Stereotactic Radiosurgery and Immune Checkpoint Inhibitor Therapy for Brain Metastases
  Koenig, J. L., Shi, S., Sborov, K., Gensheimer, M. F., Le, G., Nagpal, S., … Pollom, E. L. (2019). Adverse Radiation Effect and Disease Control in Patients Undergoing Stereotactic Radiosurgery and Immune Checkpoint Inhibitor Therapy for Brain Metastases. WORLD NEUROSURGERY, 126, E1399–E1411.
- Magnetic Resonance-Guided Laser-Induced Thermal Therapy for Recurrent Brain Metastases in the Motor Strip After Stereotactic Radiosurgery
  Iyer, A., Halpern, C. H., Grant, G. A., Deb, S., & Li, G. H. (2016). Magnetic Resonance-Guided Laser-Induced Thermal Therapy for Recurrent Brain Metastases in the Motor Strip After Stereotactic Radiosurgery. CUREUS, 8(12).
- Osimertinib for EGFR-Mutant Lung Cancer with Brain Metastases: Results from a Single-Center Retrospective Study
  Xie, L., Nagpal, S., Wakelee, H. A., Li, G., Soltys, S. G., & Neal, J. W. (2019). Osimertinib for EGFR-Mutant Lung Cancer with Brain Metastases: Results from a Single-Center Retrospective Study. ONCOLOGIST, 24(6), 836–43.
- Dual-trajectory Approach for Simultaneous Cyst Fenestration and Endoscopic Third Ventriculostomy for Treatment of a Complex Third Ventricular Arachnoid Cyst
  Ho, A. L., Pendharkar, A. V., Sussman, E. S., Ravikumar, V. K., & Li, G. H. (2015). Dual-trajectory Approach for Simultaneous Cyst Fenestration and Endoscopic Third Ventriculostomy for Treatment of a Complex Third Ventricular Arachnoid Cyst. CUREUS, 7(3).
- Topical vancomycin surgical prophylaxis in pediatric open craniotomies: an institutional experience
  Ho, A. L., Cannon, J. G. D., Mohole, J., Pendharkar, A., Sussman, E. S., Li, G., … Grant, G. A. (2018). Topical vancomycin surgical prophylaxis in pediatric open craniotomies: an institutional experience. JOURNAL OF NEUROSURGERY-PEDIATRICS, 22(6), 710–15.
- Prognostic Factors and Treatment Patterns in the Management of Giant Cell Glioblastoma
  Jin, M. C., Wu, A., Xiang, M., Azad, T. D., Soltys, S. G., Li, G., & Pollom, E. L. (2019). Prognostic Factors and Treatment Patterns in the Management of Giant Cell Glioblastoma. WORLD NEUROSURGERY, 128, E217–E224.
- Casein kinase 2 inhibition sensitizes medulloblastoma to temozolomide.
  Nitta, R. T., Bolin, S., Luo, E., Solow-Codero, D. E., Samghabadi, P., Purzner, T., … Li, G. (2019). Casein kinase 2 inhibition sensitizes medulloblastoma to temozolomide. Oncogene.
- Targeted genomic CRISPR-Cas9 screen identifies MAP4K4 as essential for glioblastoma invasion.
  Prolo, L. M., Li, A., Owen, S. F., Parker, J. J., Foshay, K., Nitta, R. T., … Grant, G. A. (2019). Targeted genomic CRISPR-Cas9 screen identifies MAP4K4 as essential for glioblastoma invasion. Scientific Reports, 9(1), 14020.
- Stereotactic Radiosurgery for Pediatric and Adult Intracranial and Spinal Ependymomas.
  Shi, S., Jin, M. C., Koenig, J., Gibbs, I. C., Soltys, S. G., Chang, S. D., … Pollom, E. L. (2019). Stereotactic Radiosurgery for Pediatric and Adult Intracranial and Spinal Ependymomas. Stereotactic and Functional Neurosurgery, 1–6.
- Nodular Leptomeningeal Disease - A Distinct Pattern of Recurrence After Post-Resection Stereotactic Radiosurgery for Brain Metastases: A Multi-Institutional Study of Inter-Observer Reliability.
  Turner, B. E., Prabhu, R. S., Burri, S. H., Brown, P. D., Pollom, E. L., Milano, M. T., … Soltys, S. G. (2019). Nodular Leptomeningeal Disease - A Distinct Pattern of Recurrence After Post-Resection Stereotactic Radiosurgery for Brain Metastases: A Multi-Institutional Study of Inter-Observer Reliability. International Journal of Radiation Oncology, Biology, Physics.
- Notch1 regulates the initiation of metastasis and self-renewal of Group 3 medulloblastoma (vol 9, 4121, 2018)
  Kahn, S. A., Wang, X., Nitta, R. T., Gholamin, S., Theruvath, J., Hutter, G., … Cheshier, S. H. (2018). Notch1 regulates the initiation of metastasis and self-renewal of Group 3 medulloblastoma (vol 9, 4121, 2018). NATURE COMMUNICATIONS, 9.
- Notch1 regulates the initiation of metastasis and self-renewal of Group 3 medulloblastoma
  Kahn, S. A., Wang, X., Nitta, R. T., Gholamin, S., Theruvath, J., Hutter, G., … Cheshier, S. H. (2018). Notch1 regulates the initiation of metastasis and self-renewal of Group 3 medulloblastoma. NATURE COMMUNICATIONS, 9.
- Correction: Casein kinase 2 inhibition sensitizes medulloblastoma to temozolomide.
  Nitta, R. T., Bolin, S., Luo, E., Solow-Cordero, D. E., Samghabadi, P., Purzner, T., … Li, G. (2019). Correction: Casein kinase 2 inhibition sensitizes medulloblastoma to temozolomide. Oncogene.
- Long-Term Update of Stereotactic Radiosurgery for Benign Spinal Tumors
  Chin, A. L., Fujimoto, D., Kumar, K. A., Tupper, L., Mansour, S., Chang, S. D., … Soltys, S. G. (2019). Long-Term Update of Stereotactic Radiosurgery for Benign Spinal Tumors. NEUROSURGERY, 85(5), 708–16.
- Non-Contrast T2-Weighted MR Sequences for Long Term Monitoring of Asymptomatic Convexity Meningiomas.
  He, J. Q., Iv, M., Li, G., Zhang, M., & Hayden-Gephart, M. (2019). Non-Contrast T2-Weighted MR Sequences for Long Term Monitoring of Asymptomatic Convexity Meningiomas. World Neurosurgery.
- Stereotactic radiosurgery for resected brain metastases: single-institutional experience of over 500 cavities.
  Shi, S., Sandhu, N., Jin, M. C., Wang, E., Jaoude, J. A., Schofield, K., … Pollom, E. L. (2019). Stereotactic radiosurgery for resected brain metastases: single-institutional experience of over 500 cavities. International Journal of Radiation Oncology, Biology, Physics.
- Outcomes and costs following Ommaya placement with thrombocytopenia among US cancer patients.
  Zhang, M., Zhang, Y., Zheng, E., Gephart, M. H., Veeravagu, A., Desai, A., … Li, G. (2019). Outcomes and costs following Ommaya placement with thrombocytopenia among US cancer patients. World Neurosurgery.
- Evaluating Shunt Survival Following Ventriculoperitoneal Shunting with and without Stereotactic Navigation in Previously Shunt-Naïve Patients.
  Jin, M. C., Wu, A., Azad, T. D., Feng, A., Prolo, L. M., Veeravagu, A., … Li, G. (2020). Evaluating Shunt Survival Following Ventriculoperitoneal Shunting with and without Stereotactic Navigation in Previously Shunt-Naïve Patients. World Neurosurgery.
- A Phase I/II Trial of 5-Fraction Stereotactic Radiosurgery with 5-mm Margins with Concurrent Temozolomide in Newly Diagnosed Glioblastoma: Primary Outcomes.
  Azoulay, M., Chang, S. D., Gibbs, I. C., Hancock, S. L., Pollom, E. L., Harsh, G. R., … Soltys, S. G. (2020). A Phase I/II Trial of 5-Fraction Stereotactic Radiosurgery with 5-mm Margins with Concurrent Temozolomide in Newly Diagnosed Glioblastoma: Primary Outcomes. Neuro-Oncology.
- Functional Mapping for Glioma Surgery: A Propensity-matched Analysis of Outcomes and Cost.
  Pendharkar, A. V., Rezaii, P. G., Ho, A. L., Sussman, E. S., Li, G., & Desai, A. M. (2020). Functional Mapping for Glioma Surgery: A Propensity-matched Analysis of Outcomes and Cost. World Neurosurgery.
- Rindopepimut with Bevacizumab for Patients with Relapsed EGFRvIII-Expressing Glioblastoma (ReACT): Results of a Double-Blind Randomized Phase II Trial.
  Reardon, D. A., Desjardins, A., Vredenburgh, J. J., O'Rourke, D. M., Tran, D. D., Fink, K. L., … Sampson, J. H. (2020). Rindopepimut with Bevacizumab for Patients with Relapsed EGFRvIII-Expressing Glioblastoma (ReACT): Results of a Double-Blind Randomized Phase II Trial. Clinical Cancer Research : an Official Journal of the American Association for Cancer Research.
- Developmental phosphoproteomics identifies the kinase CK2 as a driver of Hedgehog signaling and a therapeutic target in medulloblastoma
  Purzner, T., Purzner, J., Buckstaff, T., Cozza, G., Gholamin, S., Rusert, J. M., … Scott, M. P. (2018). Developmental phosphoproteomics identifies the kinase CK2 as a driver of Hedgehog signaling and a therapeutic target in medulloblastoma. SCIENCE SIGNALING, 11(547).
- Patterns of Care and Age-Specific Impact of Extent of Resection and Adjuvant Radiotherapy in Pediatric Pineoblastoma.
  Jin, M. C., Prolo, L. M., Wu, A., Azad, T. D., Shi, S., Rodrigues, A. J., … Grant, G. A. (2020). Patterns of Care and Age-Specific Impact of Extent of Resection and Adjuvant Radiotherapy in Pediatric Pineoblastoma. Neurosurgery.
- A PHASE 1 STUDY OF BPM31510 PLUS VITAMIN K IN SUBJECTS WITH HIGH-GRADE GLIOMA THAT HAS RECURRED ON A BEVACIZUMAB-CONTAINING REGIMEN
  Recht, L., Thomas, R., Bertrand, S., Yerballa, P., Li, G., Iv, M., … Nagpal, S. (2019). A PHASE 1 STUDY OF BPM31510 PLUS VITAMIN K IN SUBJECTS WITH HIGH-GRADE GLIOMA THAT HAS RECURRED ON A BEVACIZUMAB-CONTAINING REGIMEN. NEURO-ONCOLOGY, 21, 27.
- Local control and toxicity outcomes of stereotactic radiosurgery for spinal metastases of gastrointestinal origin.
  Sandhu, N., Benson, K. R., Kumar, K. A., Eyben, R. V., Chang, D. T., Gibbs, I. C., … Pollom, E. L. (2020). Local control and toxicity outcomes of stereotactic radiosurgery for spinal metastases of gastrointestinal origin. Journal of Neurosurgery. Spine, 1–8.
- Impact of World War I on brain mapping.
  Shah, A., Jung, H., & Li, G. (2020). Impact of World War I on brain mapping. Journal of Neurosurgical Sciences, 64(1), 113–16.
- Lumboperitoneal and Ventriculoperitoneal Shunting for Idiopathic Intracranial Hypertension Demonstrate Comparable Failure and Complication Rates
  Azad, T. D., Zhang, Y., Varshneya, K., Veeravagu, A., Ratliff, J. K., & Li, G. (2020). Lumboperitoneal and Ventriculoperitoneal Shunting for Idiopathic Intracranial Hypertension Demonstrate Comparable Failure and Complication Rates. NEUROSURGERY, 86(2), 272–80.
- Costs and Complications Associated with Resection of Supratentorial Tumors with and without the Operative Microscope in the United States.
  Zhang, Y., Zhang, M., Lin, M., Gephart, M. H., Veeravagu, A., Ratliff, J. K., & Li, G. (2020). Costs and Complications Associated with Resection of Supratentorial Tumors with and without the Operative Microscope in the United States. World Neurosurgery.
- Evaluating Surgical Resection Extent and Adjuvant Therapy in the Management of Gliosarcoma.
  Jin, M. C., Liu, E. K., Shi, S., Gibbs, I. C., Thomas, R., Recht, L., … Li, G. (2020). Evaluating Surgical Resection Extent and Adjuvant Therapy in the Management of Gliosarcoma. Frontiers in Oncology, 10, 337.
- A Comparative Analysis of Patients Undergoing Fusion for Adult Cervical Deformity by Approach Type
  Varshneya, K., Medress, Z. A., Stienen, M. N., Nathan, J., Ho, A., Pendharkar, A. V., … Veeravagu, A. (2020). A Comparative Analysis of Patients Undergoing Fusion for Adult Cervical Deformity by Approach Type. GLOBAL SPINE JOURNAL.
- Stereotactic Radiosurgery for Resected Brain Metastases - Does the Surgical Corridor Need to be Targeted?
  Shi, S., Sandhu, N., Jin, M., Wang, E., Liu, E., Jaoude, J. A., … Soltys, S. G. (2020). Stereotactic Radiosurgery for Resected Brain Metastases - Does the Surgical Corridor Need to be Targeted? Practical Radiation Oncology.
- Leptomeningeal spread with spinal involvement of pineal glioblastoma at initial presentation: A case report
  Yerneni, K., Fatemi, P., Vogel, H., Li, G., & Zygourakis, C. C. (2020). Leptomeningeal spread with spinal involvement of pineal glioblastoma at initial presentation: A case report. INTERDISCIPLINARY NEUROSURGERY-ADVANCED TECHNIQUES AND CASE MANAGEMENT, 21.
- Impact of Proton Radiotherapy on Treatment Timing in Pediatric and Adult Patients with Central Nervous System Tumors
  Jin, M. C., Shi, S., Wu, A., Sandhu, N., Xiang, M., Soltys, S. G., … Pollom, E. L. (2020). Impact of Proton Radiotherapy on Treatment Timing in Pediatric and Adult Patients with Central Nervous System Tumors. Neuro-Oncology Practice.
- Retrosigmoid Versus Translabyrinthine Approach for Acoustic Neuroma Resection: An Assessment of Complications and Payments in a Longitudinal Administrative Database
  Cole, T., Veeravagu, A., Zhang, M., Azad, T., Swinney, C., Li, G. H., … Giannotta, S. L. (2015). Retrosigmoid Versus Translabyrinthine Approach for Acoustic Neuroma Resection: An Assessment of Complications and Payments in a Longitudinal Administrative Database. CUREUS, 7(10).
- Intracranial Tumor Control Following Immune-Related Adverse Events and Discontinuation of Immunotherapy for Melanoma.
  Zhang, M., Rodrigues, A. J., Bhambhvani, H. P., Fatemi, P., Pollom, E. L., Gibbs, I. C., … Li, G. (2020). Intracranial Tumor Control Following Immune-Related Adverse Events and Discontinuation of Immunotherapy for Melanoma. World Neurosurgery.
- Commentary: The Effects of Postoperative Neurological Deficits on Survival in Patients With Single Brain Metastasis.
  Zhang, M., & Li, G. (2020). Commentary: The Effects of Postoperative Neurological Deficits on Survival in Patients With Single Brain Metastasis. Operative Neurosurgery (Hagerstown, Md.).
- Safety and Stability of Antibody-Dye Conjugate in Optical Molecular Imaging.
  Pei, J., Juniper, G., van den Berg, N. S., Nisho, N., Broadt, T., Welch, A. R., … Rosenthal, E. L. (2020). Safety and Stability of Antibody-Dye Conjugate in Optical Molecular Imaging. Molecular Imaging and Biology.
- The Effect of Socioeconomic Status on Age at Diagnosis and Overall Survival in Patients with Intracranial Meningioma.
  Brewster, R., Deb, S., Pendharkar, A. V., Ratliff, J., Li, G., & Desai, A. (2020). The Effect of Socioeconomic Status on Age at Diagnosis and Overall Survival in Patients with Intracranial Meningioma. The International Journal of Neuroscience, 1–12.
- A Comparative Analysis of Patients Undergoing Fusion for Adult Cervical Deformity by Approach Type.
  Varshneya, K., Medress, Z. A., Stienen, M. N., Nathan, J., Ho, A., Pendharkar, A. V., … Veeravagu, A. (2020). A Comparative Analysis of Patients Undergoing Fusion for Adult Cervical Deformity by Approach Type. Global Spine Journal, 2192568220915717.
- Stereotactic Radiosurgery After Resection of Brain Metastases: Changing Patterns of Care in the United States.
  Chin, A. L., Li, G., Gephart, M. H., Sandhu, N., Nagpal, S., Soltys, S. G., & Pollom, E. L. (2020). Stereotactic Radiosurgery After Resection of Brain Metastases: Changing Patterns of Care in the United States. World Neurosurgery.
- Phase I study of BPM31510 and vitamin K in patients with high grade glioma recurrent after a bevacizumab-containing regimen.
  Nagpal, S., Thomas, R. P., Bertrand, S., Yerraballa, H. P., Iv, M., Li, G., … Recht, L. D. (2020). Phase I study of BPM31510 and vitamin K in patients with high grade glioma recurrent after a bevacizumab-containing regimen. JOURNAL OF CLINICAL ONCOLOGY, 38(15).
- Adverse Events and Bundled Costs after Cranial Neurosurgical Procedures: Validation of the LACE Index Across 40,431 Admissions and Development of the LACE-Cranial Index.
  Jin, M. C., Wu, A., Medress, Z. A., Parker, J. J., Desai, A., Veeravagu, A., … Ratliff, J. K. (2020). Adverse Events and Bundled Costs after Cranial Neurosurgical Procedures: Validation of the LACE Index Across 40,431 Admissions and Development of the LACE-Cranial Index. World Neurosurgery.
- FIRST-IN-HUMAN FLUORESCENCE GUIDED SURGERY OF HIGH-GRADE GLIOMAS USING PANITUMUMAB-IRDYE800
  Zhou, Q., van den Berg, N., Nishio, N., Lu, G., Chirita, S., Raymundo, R., … Li, G. (2020). FIRST-IN-HUMAN FLUORESCENCE GUIDED SURGERY OF HIGH-GRADE GLIOMAS USING PANITUMUMAB-IRDYE800. NEURO-ONCOLOGY. OXFORD UNIV PRESS INC.
- PREOPERATIVE SINGLE FRACTION RADIOSURGERY VERSUS POSTOPERATIVE FRACTIONATED RADIOSURGERY FOR RESECTED BRAIN METASTASES: A BI-INSTITUTIONAL ANALYSIS OF SAFETY AND CLINICAL OUTCOMES
  Prabhu, R., Shi, S., Dhakal, R., Soltys, S., Burri, S., Asher, A., … Pollom, E. (2020). PREOPERATIVE SINGLE FRACTION RADIOSURGERY VERSUS POSTOPERATIVE FRACTIONATED RADIOSURGERY FOR RESECTED BRAIN METASTASES: A BI-INSTITUTIONAL ANALYSIS OF SAFETY AND CLINICAL OUTCOMES. NEURO-ONCOLOGY, 22, 184.
- Treatment patterns and outcomes for cerebellar glioblastoma in the concomitant chemoradiation era: A National Cancer database study.
  Zhang, M., Li, R., Pollom, E. L., Amini, A., Dandapani, S., & Li, G. (2020). Treatment patterns and outcomes for cerebellar glioblastoma in the concomitant chemoradiation era: A National Cancer database study. Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia, 82(Pt A), 122–27.
- An Analysis of Public Interest in Elective Neurosurgical Procedures during the COVID-19 Pandemic through Online Search Engine Trends.
  Feng, A. Y., Garcia, C. A., Jin, M. C., Ho, A. L., Li, G., Grant, G., … Skirboll, S. L. (2021). An Analysis of Public Interest in Elective Neurosurgical Procedures during the COVID-19 Pandemic through Online Search Engine Trends. World Neurosurgery.
- Improved survival and disease control following pembrolizumab-induced immune-related adverse events in high PD-L1 expressing non-small cell lung cancer with brain metastases.
  Zhang, M., Rodrigues, A. J., Pollom, E. L., Gibbs, I. C., Soltys, S. G., Hancock, S. L., … Li, G. (2021). Improved survival and disease control following pembrolizumab-induced immune-related adverse events in high PD-L1 expressing non-small cell lung cancer with brain metastases. Journal of Neuro-Oncology.
- Management of brain tumors presenting in pregnancy: a case series and systematic review
  Rodrigues, A. (2021). Management of brain tumors presenting in pregnancy: a case series and systematic review. Management of Brain Tumors Presenting in Pregnancy: a Case Series and Systematic Review, 3(1).
- Management of brain tumors presenting in pregnancy: a case series and systematic review.
  Rodrigues, A. J., Waldrop, A. R., Suharwardy, S., Druzin, M. L., Iv, M., Ansari, J. R., … Hayden-Gephart, M. (2021). Management of brain tumors presenting in pregnancy: a case series and systematic review. American Journal of Obstetrics & Gynecology MFM, 3(1), 100256.
- Financial Toxicity in Patients with Brain and Spine Metastases.
  Koenig, J. L., Sandhu, N., Sborov, K., Sabolch, A., Usoz, M., Li, G., … Pollom, E. L. (2021). Financial Toxicity in Patients with Brain and Spine Metastases. World Neurosurgery.
- Status epilepticus after intracranial neurosurgery: incidence and risk stratification by perioperative clinical features.
  Jin, M. C., Parker, J. J., Zhang, M., Medress, Z. A., Halpern, C. H., Li, G., … Skirboll, S. (2021). Status epilepticus after intracranial neurosurgery: incidence and risk stratification by perioperative clinical features. Journal of Neurosurgery, 1–13.
- Clinical factors associated with mortality within three months after radiosurgery of asymptomatic brain metastases from non-small cell lung cancer
  Kakusa, B., Han, S., Aggarwal, S., Liu, B., Li, G., Soltys, S., & Gephart, M. H. (2018). Clinical factors associated with mortality within three months after radiosurgery of asymptomatic brain metastases from non-small cell lung cancer. JOURNAL OF NEURO-ONCOLOGY, 140(3), 705–715.
- Defining and Describing Treatment Heterogeneity in New-Onset Idiopathic Lower Back and Extremity Pain Through Reconstruction of Longitudinal Care Sequences.
  Jin, M. C., Azad, T. D., Fatemi, P., Ho, A. L., Vail, D., Zhang, Y., … Ratliff, J. K. (2021). Defining and Describing Treatment Heterogeneity in New-Onset Idiopathic Lower Back and Extremity Pain Through Reconstruction of Longitudinal Care Sequences. The Spine Journal : Official Journal of the North American Spine Society.
- EGFR-targeted intraoperative fluorescence imaging detects high-grade glioma with panitumumab-IRDye800 in a phase 1 clinical trial
  Zhou, Q., van den Berg, N. S., Rosenthal, E. L., Iv, M., Zhang, M., Vega Leonel, J. C. M., … Li, G. (2021). EGFR-targeted intraoperative fluorescence imaging detects high-grade glioma with panitumumab-IRDye800 in a phase 1 clinical trial. Theranostics, 11(15).
- Risk of secondary neoplasms after external-beam radiation therapy treatment of pediatric low-grade gliomas: a SEER analysis, 1973-2015.
  Rodrigues, A. J., Jin, M. C., Wu, A., Bhambhvani, H. P., Li, G., & Grant, G. A. (2021). Risk of secondary neoplasms after external-beam radiation therapy treatment of pediatric low-grade gliomas: a SEER analysis, 1973-2015. Journal of Neurosurgery. Pediatrics, 1–9.
- Obesity in Patients Undergoing Lumbar Degenerative Surgery-A Retrospective Cohort Study of Postoperative Outcomes.
  Varshneya, K., Wadhwa, H., Stienen, M. N., Ho, A. L., Medress, Z. A., Aikin, J., … Veeravagu, A. (2021). Obesity in Patients Undergoing Lumbar Degenerative Surgery-A Retrospective Cohort Study of Postoperative Outcomes. Spine, 46(17), 1191–1196.
- Focused ultrasound: growth potential and future directions in neurosurgery.
  Zhang, M., Rodrigues, A., Zhou, Q., & Li, G. (2021). Focused ultrasound: growth potential and future directions in neurosurgery. Journal of Neuro-Oncology.
- Tumor treating fields induce DNA damage and apoptosis in medulloblastoma.
  Nitta, R. T., & Li, G. (2021). Tumor treating fields induce DNA damage and apoptosis in medulloblastoma. CANCER RESEARCH. AMER ASSOC CANCER RESEARCH.
- Intracranial Response to Combination BRAF and MEK Inhibitor Therapy in Patients with Metastatic Melanoma
  Hui, C., Wu, Y. (F., Liu, K., Sandhu, N., Blomain, E., Binkley, M., … Pollom, E. (2021). Intracranial Response to Combination BRAF and MEK Inhibitor Therapy in Patients with Metastatic Melanoma. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS. LIPPINCOTT WILLIAMS & WILKINS.
- Phase I/II Dose-Escalation Trial of 3-Fraction Stereotactic Radiosurgery for Resection Cavities From Large Brain Metastases: Health-related Quality of Life Outcomes.
  Rahimy, E., Dudley, S. A., von Eyben, R., Pollom, E. L., Seiger, K., Modlin, L., … Soltys, S. G. (2021). Phase I/II Dose-Escalation Trial of 3-Fraction Stereotactic Radiosurgery for Resection Cavities From Large Brain Metastases: Health-related Quality of Life Outcomes. American Journal of Clinical Oncology, 44(11), 588–595.
- In Vivo Evaluation of Near-Infrared Fluorescent Probe for TIM3 Targeting in Mouse Glioma.
  Zhang, M., Zhou, Q., Huang, C., Chan, C. T., Wu, W., Li, G., … Daldrup-Link, H. E. (2021). In Vivo Evaluation of Near-Infrared Fluorescent Probe for TIM3 Targeting in Mouse Glioma. Molecular Imaging and Biology.
- 18F-FSPG PET/CT Imaging of System xC- Transporter Activity in Patients with Primary and Metastatic Brain Tumors.
  Wardak, M., Sonni, I., Fan, A. P., Minamimoto, R., Jamali, M., Hatami, N., … Mittra, E. S. (2022). 18F-FSPG PET/CT Imaging of System xC- Transporter Activity in Patients with Primary and Metastatic Brain Tumors. Radiology, 203296.
- Factors for differential outcome across cancers in clinical molecular-targeted fluorescence imaging.
  Zhou, Q., van den Berg, N. S., Kang, W., Pei, J., Nishio, N., van Keulen, S., … Rosenthal, E. L. (2022). Factors for differential outcome across cancers in clinical molecular-targeted fluorescence imaging. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine.
- An integrated risk model stratifying seizure risk following brain tumor resection among seizure-naive patients without antiepileptic prophylaxis.
  Jin, M. C., Parker, J. J., Prolo, L. M., Wu, A., Halpern, C. H., Li, G., … Grant, G. A. (2022). An integrated risk model stratifying seizure risk following brain tumor resection among seizure-naive patients without antiepileptic prophylaxis. Neurosurgical Focus, 52(4), E3.
- DSC perfusion MRI-derived fractional tumor burden and relative CBV differentiate tumor progression and radiation necrosis in brain metastases treated with stereotactic radiosurgery.
  ‡Kuo, F., ‡Ng, N. N., Nagpal, S., Pollom, E. L., Soltys, S., Hayden-Gephart, M., … Iv, M. (2022). DSC perfusion MRI-derived fractional tumor burden and relative CBV differentiate tumor progression and radiation necrosis in brain metastases treated with stereotactic radiosurgery. American Journal of Neuroradiology, 43(5).
- Modifiers of and Disparities in Palliative and Supportive Care Timing and Utilization among Neurosurgical Patients with Malignant Central Nervous System Tumors.
  Jin, M. C., Hsin, G., Ratliff, J., Thomas, R., Zygourakis, C. C., Li, G., & Wu, A. (2022). Modifiers of and Disparities in Palliative and Supportive Care Timing and Utilization among Neurosurgical Patients with Malignant Central Nervous System Tumors. Cancers, 14(10).
- Brain Metastases from Gynecologic Primary Cancers: Prognostic Factors for Local Control and Overall Survival
  Mendoza, M., Janchenko, L., von Eyben, R., Kidd, E., Pollom, E., Chang, S., … Soltys, S. (2022). Brain Metastases from Gynecologic Primary Cancers: Prognostic Factors for Local Control and Overall Survival. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS. LIPPINCOTT WILLIAMS & WILKINS.
- Can tumor treating fields induce DNA damage and reduce cell motility in medulloblastoma cell lines?
  Nitta, R. T., Luo, E. J., Lim, M., & Li, G. (2022). Can tumor treating fields induce DNA damage and reduce cell motility in medulloblastoma cell lines? Journal of Neurosurgery. Pediatrics, 1–12.
- Local control of brain metastases with osimertinib alone in patients with EGFR-mutant non-small cell lung cancer.
  Hui, C., Qu, V., Wang, J.-Y. Y., von Eyben, R., Chang, Y.-C. C., Chiang, P.-L. L., … Pollom, E. (2022). Local control of brain metastases with osimertinib alone in patients with EGFR-mutant non-small cell lung cancer. Journal of Neuro-Oncology.
- Immunotherapy for inoperable gliomas
  Dadey, D., Chow, K., & Li, G. (2019). Immunotherapy for inoperable gliomas. NEW TECHNIQUES FOR MANAGEMENT OF INOPERABLE GLIOMAS, 181–192.
- Fluorescence-guided craniotomy of glioblastoma using panitumumab-IRDye800.
  Zhou, Q., & Li, G. (2022). Fluorescence-guided craniotomy of glioblastoma using panitumumab-IRDye800. Neurosurgical Focus: Video, 6(1), V9.
- Stereotactic radiosurgery for trigeminal neuralgia secondary to tumor: a single-institution retrospective series.
  Hall, J. C., Ung, T. H., McCleary, T.-L. L., Chuang, C., Gibbs, I. C., Soltys, S. G., … Meola, A. (2022). Stereotactic radiosurgery for trigeminal neuralgia secondary to tumor: a single-institution retrospective series. Neurosurgical Focus, 53(5), E3.
- Stereotactic radiosurgery for recurrent pediatric brain tumors: clinical outcomes and toxicity.
  Wang, E., Gutkin, P. M., Oh, J., Pollom, E., Soltys, S. G., Grant, G. A., … Hiniker, S. M. (2022). Stereotactic radiosurgery for recurrent pediatric brain tumors: clinical outcomes and toxicity. Neurosurgical Focus, 53(5), E2.
- MRGFUS-DELIVERED FLUORESCENT EGFR/EGFRVIII ANTIBODY ENABLES THERANOSTIC IMAGING OF PEDIATRIC HIGH-GRADE GLIOMA AND PREDICTS RESPONSE TO TARGETED THERAPY
  Zhou, Q., Aryal, M., Leonel, J. V., Santoso, M., Zlitni, A., Vogel, H., … Moseley, M. (2022). MRGFUS-DELIVERED FLUORESCENT EGFR/EGFRVIII ANTIBODY ENABLES THERANOSTIC IMAGING OF PEDIATRIC HIGH-GRADE GLIOMA AND PREDICTS RESPONSE TO TARGETED THERAPY. NEURO-ONCOLOGY. OXFORD UNIV PRESS INC.
- Intracranial Control With Combination BRAF and MEK Inhibitor Therapy in Patients With Metastatic Melanoma.
  Hui, C., Wu, Y. F., Liu, K., Sandhu, N., Blomain, E., Binkley, M. S., … Pollom, E. (2022). Intracranial Control With Combination BRAF and MEK Inhibitor Therapy in Patients With Metastatic Melanoma. Cureus, 14(11), e31838.
- A Protocol for Reducing Intensive Care Utilization After Craniotomy: A 3-Year Assessment.
  Ruiz Colón, G. D., Ohkuma, R., Pendharkar, A. V., Heifets, B. D., Li, G., Lu, A., … Ratliff, J. K. (2023). A Protocol for Reducing Intensive Care Utilization After Craniotomy: A 3-Year Assessment. Neurosurgery.
- Patterns of Progression in Patients with Newly Diagnosed Glioblastoma Treated with 5 mm Margins on a Phase I/II Trial of 5 Fraction Stereotactic Radiosurgery with Concurrent and Adjuvant Temozolomide.
  Mendoza, M. G., Azoulay, M., Chang, S. D., Gibbs, I. C., Hancock, S. L., Pollom, E. L., … Soltys, S. G. (2023). Patterns of Progression in Patients with Newly Diagnosed Glioblastoma Treated with 5 mm Margins on a Phase I/II Trial of 5 Fraction Stereotactic Radiosurgery with Concurrent and Adjuvant Temozolomide. Practical Radiation Oncology.
- Local Control of Brain Metastases with Osimertinib Alone in Patients with EGFR-Mutant Non-Small Cell Lung Cancer
  Hui, C., Qu, V., Wang, J. Y., Von Eyben, R., Chang, Y. C., Chiang, P. L., … Pollom, E. (2022). Local Control of Brain Metastases with Osimertinib Alone in Patients with EGFR-Mutant Non-Small Cell Lung Cancer. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. ELSEVIER SCIENCE INC.
- Tumor treating fields induce DNA damage and apoptosis in medulloblastoma
  Nitta, R. T., & Li, G. (2022). Tumor treating fields induce DNA damage and apoptosis in medulloblastoma. CANCER RESEARCH. AMER ASSOC CANCER RESEARCH.
- RESULTS OF A PHASE I/II TRIAL OF 5 FRACTION STEREOTACTIC RADIOSURGERY WITH CONCURRENT AND ADJUVANT TEMOZOLOMIDE IN NEWLY DIAGNOSED SUPRATENTORIAL GLIOBLASTOMA MULTIFORME
  Azoulay, M., Fujimoto, D., Modlin, L., Ho, C., Gibbs, I., Hancock, S. L., … Soltys, S. G. (2016). RESULTS OF A PHASE I/II TRIAL OF 5 FRACTION STEREOTACTIC RADIOSURGERY WITH CONCURRENT AND ADJUVANT TEMOZOLOMIDE IN NEWLY DIAGNOSED SUPRATENTORIAL GLIOBLASTOMA MULTIFORME. RADIOTHERAPY AND ONCOLOGY. ELSEVIER IRELAND LTD.
- Stereotactic Radiosurgery and Hypofractionated Radiotherapy for Glioblastoma
  Shah, J. L., Li, G., Shaffer, J. L., Azoulay, M. I., Gibbs, I. C., Nagpal, S., & Soltys, S. G. (2018). Stereotactic Radiosurgery and Hypofractionated Radiotherapy for Glioblastoma. NEUROSURGERY, 82(1), 24–34.
- CASEIN KINASE 2 REGULATES EXPRESSION AND ACTIVITY OF MYC IN GROUP 3 MEDULLOBLASTOMA
  Jin, B., Nitta, R., & Li, G. (2016). CASEIN KINASE 2 REGULATES EXPRESSION AND ACTIVITY OF MYC IN GROUP 3 MEDULLOBLASTOMA. NEURO-ONCOLOGY. OXFORD UNIV PRESS INC.
- ReACT: Overall survival from a randomized phase II study of rindopepimut (CDX-110) plus bevacizumab in relapsed glioblastoma
  Reardon, D. A., Schuster, J., Tran, D. D., Fink, K. L., Nabors, L. B., Li, G., … Sampson, J. H. (2015). ReACT: Overall survival from a randomized phase II study of rindopepimut (CDX-110) plus bevacizumab in relapsed glioblastoma. JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY.
- CASEIN KINASE 2 ALPHA REGULATES GBM CANCER STEM CELL GROWTH THROUGH THE BETA-CATENIN PATHWAY
  Nitta, R., Mitra, S., Agarwal, M., Bui, T., & Li, G. (2013). CASEIN KINASE 2 ALPHA REGULATES GBM CANCER STEM CELL GROWTH THROUGH THE BETA-CATENIN PATHWAY. NEURO-ONCOLOGY. OXFORD UNIV PRESS INC.
- GAMMA-GLUTAMYL TRANSFERASE 7 ACTS AS A TUMOR SUPPRESSOR IN GBM AND CORRELATES WITH GOOD PROGNOSIS
  Bui, T., Nitta, R., & Li, G. (2013). GAMMA-GLUTAMYL TRANSFERASE 7 ACTS AS A TUMOR SUPPRESSOR IN GBM AND CORRELATES WITH GOOD PROGNOSIS. NEURO-ONCOLOGY. OXFORD UNIV PRESS INC.
- IKAROS EXPRESSION INHIBITS GBM TUMORIGENESIS AND CORRELATES WITH A POSITIVE PROGNOSIS
  Agarwal, M., Nitta, R., Dovat, S., & Li, G. (2013). IKAROS EXPRESSION INHIBITS GBM TUMORIGENESIS AND CORRELATES WITH A POSITIVE PROGNOSIS. NEURO-ONCOLOGY. OXFORD UNIV PRESS INC.
- Skull-Base Tumors F. Role of Radiosurgery for Sellar Lesions
  Jiang, B., Hara, W., & Li, G. (2013). Skull-Base Tumors F. Role of Radiosurgery for Sellar Lesions. HANDBOOK OF RADIOSURGERY IN CNS DISEASE, 103–110.
- Skull Base Tumors A. Radiosurgery for Skull Base Meningioma
  Moreno, M., Bui, T., & Li, G. (2013). Skull Base Tumors A. Radiosurgery for Skull Base Meningioma. HANDBOOK OF RADIOSURGERY IN CNS DISEASE, 59–65.
- Hydrocephalus
  Li, G., & Fisher, P. G. (2010). Hydrocephalus. JOURNAL OF PEDIATRICS, 156(3), 438.
- Advancements without consensus: differing practice patterns highlight unanswered questions in the management of brain metastases from<i> EGFR-</i> and<i> ALK</i>-positive non-small cell lung cancer
  Hui, C., Pollom, E. L., Li, G., & Myall, N. J. (2023). Advancements without consensus: differing practice patterns highlight unanswered questions in the management of brain metastases from EGFR- and ALK-positive non-small cell lung cancer. JOURNAL OF THORACIC DISEASE.
- Impact of language barriers and use of interpreters on hope among patients with Central Nervous System Malignancies and Bone Metastases.
  Hui, C., Hall, J., Fang, Z., Lefebvre, S., Hayden-Gephart, M., Li, G., … Pollom, E. (2023). Impact of language barriers and use of interpreters on hope among patients with Central Nervous System Malignancies and Bone Metastases. International Journal of Radiation Oncology, Biology, Physics.
- Advancements without consensus: differing practice patterns highlight unanswered questions in the management of brain metastases from EGFR- and ALK-positive non-small cell lung cancer.
  Hui, C., Pollom, E. L., Li, G., & Myall, N. J. (2023). Advancements without consensus: differing practice patterns highlight unanswered questions in the management of brain metastases from EGFR- and ALK-positive non-small cell lung cancer. Journal of Thoracic Disease, 15(11), 5877–5884.
- MITOCHONDRIAL ATP BIOGENESIS REGULATED BY VDAC1 IN TMEM119+TUMOR-ASSOCIATED MICROGLIA AND MACROPHAGES MEDIATES HIGH-GRADE GLIOMA GROWTH
  Wu, C., Chen, Y., Lin, Y.-J., Wei, K.-C., Chang, K.-Y., Feng, L.-Y., … Lim, M. (2023). MITOCHONDRIAL ATP BIOGENESIS REGULATED BY VDAC1 IN TMEM119+TUMOR-ASSOCIATED MICROGLIA AND MACROPHAGES MEDIATES HIGH-GRADE GLIOMA GROWTH. NEURO-ONCOLOGY. OXFORD UNIV PRESS INC.
- CyberKnife stereotactic radiosurgery for extramedullary plasmacytoma in the external auditory canal: illustrative case.
  Patil, S., Shaghaghian, E., Yuan, L., Shah, A., Marianayagam, N. J., Park, D. J., … Chang, S. D. (2024). CyberKnife stereotactic radiosurgery for extramedullary plasmacytoma in the external auditory canal: illustrative case. Journal of Neurosurgery. Case Lessons, 7(19).
- The cytokine Meteorin-like inhibits anti-tumor CD8+ T cell responses by disrupting mitochondrial function.
  Jackson, C. M., Pant, A., Dinalankara, W., Choi, J., Jain, A., Nitta, R., … Lim, M. (2024). The cytokine Meteorin-like inhibits anti-tumor CD8+ T cell responses by disrupting mitochondrial function. Immunity.
- The CCR6-CCL20 axis promotes regulatory T cell glycolysis and immunosuppression in tumors.
  Pant, A., Jain, A., Chen, Y., Patel, K., Saleh, L., Tzeng, S., … Jackson, C. M. (2024). The CCR6-CCL20 axis promotes regulatory T cell glycolysis and immunosuppression in tumors. Cancer Immunology Research.
- Cross-cultural serious neurological illness communication: qualitative analysis of multidisciplinary perspectives.
  Wu, A., Giannitrapani, K. F., Ruiz Colón, G. D., Adams, A. S., Li, G., & Lorenz, K. A. (2024). Cross-cultural serious neurological illness communication: qualitative analysis of multidisciplinary perspectives. Annals of Palliative Medicine.
- KEAP1-mutant atypical meningioma: illustrative case.
  Harary, P. M., Hori, Y. S., Persad, A. R., Tayag, A., Ustrzynski, L., Emrich, S. C., … Chang, S. D. (2024). KEAP1-mutant atypical meningioma: illustrative case. Journal of Neurosurgery. Case Lessons, 8(11).

View More Publications

Clinical Trials

Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.

Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.

Open Trials Closed Trials

Exablate Blood-Brain Barrier Disruption for the Treatment of rGBM in Subjects Undergoing Carboplatin Monotherapy

Practice Locations

Brain and Spine Tumor Center at Stanford Neuroscience Health Center Palo Alto, CA

Palo Alto, CA

Brain and Spine Tumor Center at Stanford Neuroscience Health Center

213 Quarry Rd

Palo Alto , CA 94304

(650) 497-7777

More Clinic Information

CyberKnife Program at the Neuroscience Health Center Palo Alto, CA

Palo Alto, CA

CyberKnife Program at the Neuroscience Health Center

213 Quarry Rd

Palo Alto , CA 94304

(650) 725-0084

More Clinic Information

Skull Base Surgery at the Neuroscience Health Center Palo Alto, CA

Palo Alto, CA

Skull Base Surgery at the Neuroscience Health Center

213 Quarry Rd

Palo Alto , CA 94304

(650) 497-7777

More Clinic Information

Stanford Neuroscience Health Center Palo Alto, CA

Palo Alto, CA

Stanford Neuroscience Health Center

213 Quarry Rd

Palo Alto , CA 94304

(650) 723-6469

More Clinic Information

Neurocritical Care Program Stanford, CA

Stanford, CA

Neurocritical Care Program

300 Pasteur Drive, 3rd Floor

Stanford , CA 94305

+1 (866) 742-4811

More Clinic Information

Pituitary Center Palo Alto, CA

Palo Alto, CA

Pituitary Center

213 Quarry Rd

Palo Alto , CA 94304

(650) 723-6469

More Clinic Information

Neurosurgery Program Palo Alto, CA

Palo Alto, CA

Neurosurgery Program

213 Quarry Rd

Palo Alto , CA 94304

(650) 723-6469

More Clinic Information

Important Information about Our Organizations and Physician Affiliation

Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners are each independent nonprofit organizations that are affiliated with but separate from each other and from Stanford University. The physicians who provide care at facilities operated by Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners are faculty, foundation, or community physicians who are not employees, representatives, or agents of Stanford Health Care, Stanford Health Care Tri- Valley, or Stanford Medicine Partners. Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners do not exercise control over the care provided by such faculty, foundation, and community physicians and are not responsible for their actions.

Patient Ratings

(31 Ratings)

Overall Rating

4.9/5

View Ratings by Category

5.0/5

Friendliness

4.9/5

Explanations

4.9/5

Listens

4.9/5

Care provider's efforts to include you in decisions about your care

5.0/5

Recommended to others

0.0/5

Wait times

How Our Ratings Work

The Patients Ratings and comments are gathered from our Patient Satisfaction Survey and displayed in their entirety.

Patient Satisfaction Survey Disclaimer

Patient Reviews

(222 reviews)

Answered all my questions along with Lanchi , Nurse practitioner.

Oct 2024

•

Verified SHC Patient

Dr. Li was his usual very helpful and friendly self. He listened to my descriptions of how I am doing with my shunt and provided thoughtful responses. The video format worked well.

Oct 2024

•

Verified SHC Patient

He is a wonderful doctor and has a wonderful team. I appreciate that they didn't just brush me aside. They removed my acoustic neuroma which removed a lot of pressure from my head and I feel much better because of it. I am grateful!

Oct 2024

•

Verified SHC Patient

Dr Li is a very understanding and informative doctor and always answers my questions and concerns. I enjoy talking with him.

Sep 2024

•

Verified SHC Patient

Gordon Li has the best bedside manner of any surgeon! He is compassionate, a clear communicator and so very knowledgeable.

Sep 2024

•

Verified SHC Patient

Awesome! Professional Smart Compassionate Not rushed

Sep 2024

•

Verified SHC Patient

He is amazing. Not rushed. Thorough. Compassionate. Instills confidence

Sep 2024

•

Verified SHC Patient

Dr. Li was excellent in presenting the information and has increased my confidence in surgery as an option.

Aug 2024

•

Verified SHC Patient

Very good.

Aug 2024

•

Verified SHC Patient

Dr. Li was very thorough. He put me at ease by beginning with his medical interpretation of my brain MRI results then followed with detailed explanation and next steps moving forward.

Jul 2024

•

Verified SHC Patient

Thank you so much for the clear explanation. I appreciate it.

Jul 2024

•

Verified SHC Patient

Patient and professional

Jul 2024

•

Verified SHC Patient

Stanford is well organized and very professional.

Jul 2024

•

Verified SHC Patient

I researched him and was very satisfied with his credentials. In person he was to the point, answered all my questions, friendly, patient and had a sense of humor. Can't think of any way in which he was lacking.

Jul 2024

•

Verified SHC Patient

Dr. LI is a great doctor, very patient and answers all my questions and I feel better after speaking to him. I am very happy he is helping with my cancer.

Jul 2024

•

Verified SHC Patient

Thank You for all you do. Thank You for all of your experience and care.ðŸ™ ðŸ«¶ðŸ‡ºðŸ‡¸

Jul 2024

•

Verified SHC Patient

V pleasant, understanding the problems experienced by patient, helpful suggestions, knowledgeable and caring

Jun 2024

•

Verified SHC Patient

Helpful

Jun 2024

•

Verified SHC Patient

I appreciate that Dr. Li takes the time to converse with me on video even though I know heâ€™s quite busy

Jun 2024

•

Verified SHC Patient

Outstanding!!!

May 2024

•

Verified SHC Patient

Dr Li is an amazing surgeon, he has been a part of every follow up MRI I've had since my surgery in 2017, and I appreciate that so much!

May 2024

•

Verified SHC Patient

He is a very confident Doctor to talk with and makes you understand what is happening and what will be done next which as a patient I really appreciate. I am happy he is on my team and look forward to his valuable help with my illness.

May 2024

•

Verified SHC Patient

I love and respect him, very caring, and knowledgeable. I trust him so much.

May 2024

•

Verified SHC Patient

Wonderful doctor! He listens to the patient.

May 2024

•

Verified SHC Patient

Dr. Li has been nothing short of amazing! Upon first meeting him prior to my acoustic neuroma brain surgery, his calm confidence and reassurance provided me and my family the belief that my life was in excellent hands. He was attentive and answered all of my questions as well as those from my family. After surgery, he and his team were always available. I am very grateful.

May 2024

•

Verified SHC Patient

The doctor provided all the information I needed and answered my questions on follow-up issues. Excellent treatment.

Apr 2024

•

Verified SHC Patient

He basically saved my life I owe him that

Apr 2024

•

Verified SHC Patient

He was very helpful and explanatory. Answered all my questions in a calm unhurried fashion.

Apr 2024

•

Verified SHC Patient

What a good person he is becomes clear in a meeting with him. He helped us find ways to understand how best to make decisions about our medical issues.

Apr 2024

•

Verified SHC Patient

Dr. Li is an outstanding surgeon! He is extremely knowledgeable and helpful. He is compassionate, kind, and caring. He is THE reason why Stanford Hospital has its world-class image. I feel so blessed that I was able to have Dr. Li do my surgery. I would highly recommend Dr. Li. He is a 10 out of 10!

Apr 2024

•

Verified SHC Patient

Excellent physician. Very warm, caring, attentive and thorough

Mar 2024

•

Verified SHC Patient

Wonderful person.

Mar 2024

•

Verified SHC Patient

Dr. Gordon Li is a very pleasant doctor. Not intimidating at all. Treats me with a lot of patience and willingness to answer my questions. No air of arrogance but gives me confidence that I am being cared for by a knowledgeable and experienced doctor. His words are reassuring and gives me comfort that I am healing well. The consultation I have with Dr. Li is part of my healing process. Dr. Li telling me that he will continue to monitor my case closely with follow up MRIs is very therapeutic like a large dose of medicine in itself. I am definitely, in good hands.

Mar 2024

•

Verified SHC Patient

Dr. Gordon Li was very patient, caring and knowledgeable. He went over my health issues and explained in detail about recent findings from CT scan. He also provided steps for the future. Plans. I feel lucky to be under best care!

Feb 2024

•

Verified SHC Patient

Dr Li answers all questions that I have. His responses are always in a positive tone. Today was the greatest news I have received; my tumor is dead.

Feb 2024

•

Verified SHC Patient

He is very thorough and patient

Feb 2024

•

Verified SHC Patient

Dr. Li was courteous and detailed easy to communicate with.

Feb 2024

•

Verified SHC Patient

He's a very knowledgeable doctor,he knows the answer on every question i had. Easy to communicate with him

Jan 2024

•

Verified SHC Patient

Professional Manner

Jan 2024

•

Verified SHC Patient

Dr.Li is an excellent doctor. He always explains things very well. He is also very caring and patient. After talking to him, I feel much better about my situation. I feel very lucky having him as my doctor.

Jan 2024

•

Verified SHC Patient

great

Jan 2024

•

Verified SHC Patient

Dr Li was pleasant to speak with., appears to be genuinely interested in delivering updates and good news regarding my MRI result. Iâ€™m blessed to have him as one of my MDs.

Jan 2024

•

Verified SHC Patient

Very pleasant to speak with and knowledgeable about my condition

Nov 2023

•

Verified SHC Patient

He is pleasant and very knowledgeable.

Oct 2023

•

Verified SHC Patient

Excellent doctor who cares about his patients.

Oct 2023

•

Verified SHC Patient

Excellent visit

Oct 2023

•

Verified SHC Patient

Dr. Li was very helpful and caring. We wish we had been able to have a referral with him earlier to help with my Mom's brain tumor.

Oct 2023

•

Verified SHC Patient

He was very caring and cordial, extremely knowledgeable and I have confidence in him.

Sep 2023

•

Verified SHC Patient

Excellent Doctor to talk with. I feel lucky to be in his care.

Aug 2023

•

Verified SHC Patient

Dr. Gordon Li is very personable and has addressed all my concerns during my first visit in office and also today even when we had a video call. He has so much empathy to my condition and I feel very at ease and comfortable being his new patient. Thank you so very much, Dr. Li! God bless you.

Aug 2023

•

Verified SHC Patient

Answered my questions and care going forward.

Jul 2023

•

Verified SHC Patient

He is very outstanding.

Jul 2023

•

Verified SHC Patient

He is an amazing surgeon, and I am so lucky to have him and his team on my side!!

May 2023

•

Verified SHC Patient

Always excellent patient care and attentiveness

May 2023

•

Verified SHC Patient

Very competent , compassionate doctor

May 2023

•

Verified SHC Patient

Dr. Li was extremely professional and I feel dry comfortable with him and his team!

Apr 2023

•

Verified SHC Patient

Dr. Li is always thorough and positive when explaining the results for my brain MRI.

Jan 2023

•

Verified SHC Patient

I thought Dr Li had Great bedside manner. He was Very caring and helpful.

Jan 2023

•

Verified SHC Patient

Always accommodating and reassuring. Thank you

Jan 2023

•

Verified SHC Patient

I've had 3 cancer surgeries at Stanford since February 2017. Everyone I've encountered during my cancer journey have been highly competent, knowledgeable, fully engaged in my treatment care and supportive of one another. Dr Beth Beadle mentioned before my first surgery that with cancer and the need for follow-on care, my team becomes a "family" and 6 years later I can see that she is right. Dr Li epitomizes all the above and I value his expertise.

Jan 2023

•

Verified SHC Patient

Dr. Li is an excellent example of why Stanford has such a stellar reputation. Amazing "bed-side" manner. So approachable.

Jan 2023

•

Verified SHC Patient

Dr Li is very informative when asked questions he is compassionate and I enjoy our conversations

Jan 2023

•

Verified SHC Patient

they are specialist and good at what they do

Dec 2022

•

Verified SHC Patient

Thorough, compassionate, discussed his opinions and options available. Collaborative.

Nov 2022

•

Verified SHC Patient

Great visit!

Nov 2022

•

Verified SHC Patient

very thorough

Oct 2022

•

Verified SHC Patient

He was very personable and helpful.

Oct 2022

•

Verified SHC Patient

Dr. Li is my favorite neurosurgeon.

Sep 2022

•

Verified SHC Patient

Dr. Li was very attentive as I am dealing with some serious medical issues and answered all of my questions regarding my treatment. He is a great doctor who takes the time to hear my questions and concerns.

Sep 2022

•

Verified SHC Patient

He answered our questions with careful thought and clarity. He was very knowledgeable about the topic, and gave us great confidence that the procedure we were contemplating to do was the right choice given the constraints we had. Well worth the time and money for the excellent feedback he gave us.

Sep 2022

•

Verified SHC Patient

Very friendly and hopeful

Sep 2022

•

Verified SHC Patient

Easy communication. With his assistant gave me plenty of time. I wouldnâ€™t hesitate to contact him if I thought it necessary.

Aug 2022

•

Verified SHC Patient

I was able to schedule an appointment with Dr Li and the response from the Neurology department has been very helpful in addressing my concerns.

Aug 2022

•

Verified SHC Patient

Satisfied with explanation for my scenario and now have peace on mind!

Jul 2022

•

Verified SHC Patient

DR. Li is very personable and a caring physician. He tries to explain my results to me (even though it is foreign to me!). He answers every question I have as best he can.

Jun 2022

•

Verified SHC Patient

The visit was easy to connect and the info was communicated well.

Jun 2022

•

Verified SHC Patient

Doctor Li was great.

Jun 2022

•

Verified SHC Patient

I'm a big fan! Did a fabulous job, kind, concerned, and takes time to explain things. Reassuring.

Jun 2022

•

Verified SHC Patient

Good doctor

May 2022

•

Verified SHC Patient

He looks like a very caring person and looking forward to meeting him

May 2022

•

Verified SHC Patient

He asked all my questions in a manner that I was able to u dear and fully.

Apr 2022

•

Verified SHC Patient

He is very thorough and explains what is happening and what the plan is. I highly recommend him.

Mar 2022

•

Verified SHC Patient

Overall I had a great experience with Dr Gordon Li. He's a great doctor.

Mar 2022

•

Verified SHC Patient

Fantastic doctor. The operational pieces with the surgery was not ideal

Mar 2022

•

Verified SHC Patient

Very good

Mar 2022

•

Verified SHC Patient

Very nice visit.

Mar 2022

•

Verified SHC Patient

Dr Li is very knowledgeable and courteous.

Jan 2022

•

Verified SHC Patient

Doctor Li is very carrying

Jan 2022

•

Verified SHC Patient

Excellent surgeon he saved my life.

Jan 2022

•

Verified SHC Patient

Dr. Li explained the results of my MRI of my Brain and the plan moving forward and when I need to have a followup scan. If I have any other issues he said I can always have the scan sooner than the recommended followup. I didn't realize I could still have tumors there after the cyberknife radiation, they just may not be active, so I was suprised and concerned about this finding for the future.

Jan 2022

•

Verified SHC Patient

Dr. Li answered all my questions and concerns. I was very satisfied with the appointment.

Jan 2022

•

Verified SHC Patient

Very nice

Dec 2021

•

Verified SHC Patient

Thank you for the care you provide I appreciate all that has been done thus far.

Dec 2021

•

Verified SHC Patient

Good first visit! We need a new CT scan as a follow up.

Nov 2021

•

Verified SHC Patient

From the ED, the Urology clinic, to Dr. Li and his team, I have received nothing but outstanding care from all personnel!

Nov 2021

•

Verified SHC Patient

I would recommend Dr. Gordon Li and his team, and Stanford Health Care in general to others. The care/services is stellar.

Nov 2021

•

Verified SHC Patient

Dr. Gordon Li is an amazing doctor and he has been very helpful and informative from the very beginning. I feel very lucky to have been able to have him as my doctor and Iâ€™m grateful for the experience he provided. I would like to give my thanks to him because I know that the work he does requires years of schooling and if it wasnâ€™t for people like him that took the time and effort to become the amazing doctors that are available to us who need them, who knows where we would be. I would like Dr. Gordon Li to know that I am very grateful to him. I feel as though I had the very best treatment available to me because of him.

Oct 2021

•

Verified SHC Patient

Dr. Li has been wonderful starting with my initial consultation and all the way along through my surgery and the time following the surgery while I was in the hospital. He has followed me closely while I was recuperating at home, and has been monitoring my progress as I have had 2 post surgery MRIs. I feel very lucky that I was able to have Dr. Li do my surgery, and I am very happy with the results. I would highly recommend Dr. Li.

Oct 2021

•

Verified SHC Patient

I would recommend highly of the physician and getting medical care at Stanford healthcare

Oct 2021

•

Verified SHC Patient

The video call option works well for me because I am out of state and Dr Li is amazing surgeon!

Oct 2021

•

Verified SHC Patient

Dr Li is outstanding! Heâ€™s on time too. Iâ€™m confident that getting the best care possible with Dr Li.

Sep 2021

•

Verified SHC Patient

Great experience!

Sep 2021

•

Verified SHC Patient

He is a great doctor and has a good personality for this type of care.

Sep 2021

•

Verified SHC Patient

Dr. Li is absolutely amazing & his staff. Lanchi his nurse is fantastic and checks on me thru the patient portal & is quick to respond to any questions or concerns I have. I come all the way from Texas when I need brain surgery to because of Dr. Li. He is EXCELLENT and 5 out 5 STARS â ï¸

Sep 2021

•

Verified SHC Patient

Thank you for a very comprehensive appointment.

Jul 2021

•

Verified SHC Patient

No comments

Jul 2021

•

Verified SHC Patient

Great chat. To the point and friendly. Great professional resource.

Jun 2021

•

Verified SHC Patient

He is very encouraging and told me what we would be doing next with my MRI,s which was good news. He has always been very helpful and has a good outlook for me.

May 2021

•

Verified SHC Patient

Excellent.

May 2021

•

Verified SHC Patient

His assistant was very helpful

May 2021

•

Verified SHC Patient

Nice doctor very helpful

Apr 2021

•

Verified SHC Patient

Great doctor, knew his stuff.

Apr 2021

•

Verified SHC Patient

Very great Doctor and explains the information thoroughly. He makes sure you are assured of what is going on and that all your questions are answered.

Apr 2021

•

Verified SHC Patient

Very clear message and path forward

Apr 2021

•

Verified SHC Patient

I was so impressed by Dr. Gordan Ho-Wan Li. He was very compassionate and had an excellent bedside manner.

Apr 2021

•

Verified SHC Patient

Good.

Apr 2021

•

Verified SHC Patient

Excellent service.

Mar 2021

•

Verified SHC Patient

Dr. Li listens well and is great at making his patients feel reassured.

Jan 2021

•

Verified SHC Patient

Doctor made sure he answered all our questions. He recommended what we should do -

Dec 2020

•

Verified SHC Patient

Dr. Li is great!

Oct 2020

•

Verified SHC Patient

Dr. Li continues to prove himself to be an outstanding physician and he always show concern about my physical well-being.

Jun 2020

•

Verified SHC Patient

Highly professional.

Mar 2020

•

Verified SHC Patient

Very positive experience with Dr. Gordon Li. This was a post-op check up. Thoroughly examined the wound site. Answered all our questions in a way that we understood.

Jan 2020

•

Verified SHC Patient

Dr. Li and his assistant are very friendly, making me feel comfortable during the visit.

Jan 2020

•

Verified SHC Patient

Great care every visit.

Dec 2019

•

Verified SHC Patient

Dr. Li is one of the best doctors I ever meet he is very friendly and kind and caring.

Dec 2019

•

Verified SHC Patient

Dr. Li and his staff are consistently EXCELLENT!

Dec 2019

•

Verified SHC Patient

Dr. Li was wonderful! Took his time, wonderful bedside manners, patient, very informative.

Nov 2019

•

Verified SHC Patient

Good experience.

Oct 2019

•

Verified SHC Patient

Dr. Gordon Li is THE BEST OF THE BEST!! Stanford Health Care should be proud of having such a fine medical provider in the team!!

Oct 2019

•

Verified SHC Patient

Very good experience. 10. Highly recommend.

Oct 2019

•

Verified SHC Patient

Dr. Li's integrity & quality as a surgeon & person are evident in how well he treats me. Under his care, I have had the best experience one can ever have undergoing major surgery.

Oct 2019

•

Verified SHC Patient

Dr. Li is excellent!

Sep 2019

•

Verified SHC Patient

Dr. Li is intelligent and respectful of me and my medical situation. Excellent!

Sep 2019

•

Verified SHC Patient

I have nothing but praise for Dr. Li and his nurse practitioner. Both of them are very competent, caring and compassionate.

Sep 2019

•

Verified SHC Patient

I always enjoy my visits with Dr. Li and his staff. They are very professional and caring.

Sep 2019

•

Verified SHC Patient

Always great experience with Dr. Li.

Jul 2019

•

Verified SHC Patient

Dr. Li is thorough, kind & always reassuring.

Jul 2019

•

Verified SHC Patient

Always enjoy my time and discussion of my health with Dr. Li and his staff.

Jul 2019

•

Verified SHC Patient

Very clear on process and expectations.

Jun 2019

•

Verified SHC Patient

I always enjoy my time with Dr. Li.

Mar 2019

•

Verified SHC Patient

Dr. Li is a very personable and professional. I felt comfortable asking questions. He was very kind and supportive. Excellent suggestions and information.

Mar 2019

•

Verified SHC Patient

Dr. Li is a wonderful doctor (care provider).

Feb 2019

•

Verified SHC Patient

Good.

Feb 2019

•

Verified SHC Patient

I'm very grateful for Dr. Li's care & expertise.

Jan 2019

•

Verified SHC Patient

Dr. Gordon Li was wonderful - he had a GREAT patient manner & was so caring and reassuring in his treatment plan & explanation. It made a good deal to me & I so appreciated his kindness.

Dec 2018

•

Verified SHC Patient

Dr. Li is truly an amazing doctor.

Dec 2018

•

Verified SHC Patient

I highly recommend this care provider. Dr Gordon Li is a great doctor who treats patient very well. He understands patients health and try to give his best to treat.

Dec 2018

•

Verified SHC Patient

I am very happy to be treated by Dr. Gordon Li. Thank you Stanford for great doctor!!!

Oct 2018

•

Verified SHC Patient

Dr. Gordon Li is very kind and treats very well. He is very caring and concerned about patients. I would definitely recommend. He is a great surgeon.

Sep 2018

•

Verified SHC Patient

Highly recommend Stanford for medical care.

Aug 2018

•

Verified SHC Patient

Dr. Li is the best! He saved my life.

Aug 2018

•

Verified SHC Patient

We felt privileged that he took the time to fit us into his schedule. He made us feel comfortable when asking questions and was very sympathetic towards our situation.

Jul 2018

•

Verified SHC Patient

I was very impressed with Dr. Li's visits at the hospital after surgery - He has a wonderful bedside manner to instill hope and confidence during recovery -

Jul 2018

•

Verified SHC Patient

Dr. Li was very considerate and thorough with all my detailed questions.

May 2018

•

Verified SHC Patient

Dr. Gordon Li was great at listening to all my concerns and providing the appropriate response. He even went the extra mile to suggest renewing my MRI with the tumor board.

May 2018

•

Verified SHC Patient

Dr. Li was very professional and knowledgable regarding my case. He answered all my questions regarding my condition.

May 2018

•

Verified SHC Patient

Satisfied with the amiability and courtesy.

Apr 2018

•

Verified SHC Patient

I had the most incredible clinic visit with Dr. Gordon Li. He was compassionate, thorough, and kind. He made me reassured about my condition. My procedure, and instilled absolute.

Apr 2018

•

Verified SHC Patient

I was specifically referred to Dr. Li for his high reputation. I certainly was not disappointed with his expertise or communication skills and care.

Apr 2018

•

Verified SHC Patient

Did not seem rushed, gave me great attention and explanation of what was going on. Very impressive.

Apr 2018

•

Verified SHC Patient

Especially Dr. Li.

Mar 2018

•

Verified SHC Patient

Dr. Li was clear and understandable. I didn't feel rushed. He answered all my questions.

Feb 2018

•

Verified SHC Patient

I had the good fortune to have Dr. Gordon Li as my Doctor. He was kind, soft spoken, patient and caring. He made me feel at ease and confident to have him treat me. He basically walks on water for me!!!

Jan 2018

•

Verified SHC Patient

Dr. L. is amazing!! I cannot believe how blessed I was to be referred to him. He's extremely sensitive to his patients and instills confidence in the medical process & procedure.

Dec 2017

•

Verified SHC Patient

Dr. Gordan Li in an elite class. Very thankful for his expertise. I'm still here for my family thanks to Dr. Li.

Nov 2017

•

Verified SHC Patient

Excellent!!!

Oct 2017

•

Verified SHC Patient

I love Dr. Gordon Li!

Oct 2017

•

Verified SHC Patient

"Great experience with Dr. G. Li. Very fortunate to have him as my brain neurosurgeon!!

Oct 2017

•

Verified SHC Patient

I couldn't be in better hands - I'm so grateful to have such a skilled and kind surgeon. If I'd stayed with my healthcare in Hawaii, I'd probably not be around anymore. He took a handle of the situation.

Sep 2017

•

Verified SHC Patient

Never felt rushed. Also a full explanation and spent all the time needed until all my questions were answered.

Sep 2017

•

Verified SHC Patient

Very good experience. The doctor was very knowledgable & set me at ease. He patiently explained to me & what the problem was & reassured me.

Sep 2017

•

Verified SHC Patient

Excellent, I was worried coming in. Recommendations made sense. I left with my questions answered.

Aug 2017

•

Verified SHC Patient

Dr. Li was so attentive and took time out of his schedule to call and speak with me twice about my condition & treatment options.

Jul 2017

•

Verified SHC Patient

I have nothing more to say than give thanks to the good lord for Dr. Li and his team. He's an outstanding doctor.

Jun 2017

•

Verified SHC Patient

Dr. Gordon was knowledgeable, compassionate, with clear communication regarding prognosis & treatment. He gave us plenty of time to ask questions & understand a difficult situation.

Jun 2017

•

Verified SHC Patient

Dr. Li is wonderful! He makes you feel that you are his only patient. I hope he never leaves the practice!

Jun 2017

•

Verified SHC Patient

Dr. Gordon Li is a "personality plus" doctor - He is so kind and totally focuses on you and your problem. Very patient person, very sweet.

May 2017

•

Verified SHC Patient

Dr. Li is an exceptional physician & care provider. Without a doubt one of the finest doctors I've had the extreme good fortune (all things considered) to have as a key part of my team. In addition to the personal ? warmth/empathy he has & shows is a tremendous boost to my treatment, trust, & confidence in my overall care & my feeling that I am in exceptionally good hands.

May 2017

•

Verified SHC Patient

Dr. Li spent a considerable amount of time with me. I appreciate his time and patience.

May 2017

•

Verified SHC Patient

Very good.

Apr 2017

•

Verified SHC Patient

Dr. Li is awesome!

Mar 2017

•

Verified SHC Patient

Dr. Li was outstanding in his care and informing me of expectations I will have in my future.

Mar 2017

•

Verified SHC Patient

Dr.Li was outstanding with regard to informing me of what the issue was.

Mar 2017

•

Verified SHC Patient

In addition to being a skilled surgeon, Dr. Li has always been kind and compassionate. He takes the time to explain things and never seems rushed.

Mar 2017

•

Verified SHC Patient

Great services provided. Enjoyed taking w/Dr. Li and NP.

Jan 2017

•

Verified SHC Patient

Did feel a little rushed. But overall great experience.

Jan 2017

•

Verified SHC Patient

Amazing how well Dr. Li takes his immense knowledge and communicates so clearly and openly. It's great having a two-way conversation and learning from him!

Jan 2017

•

Verified SHC Patient

Very good

Dec 2016

•

Verified SHC Patient

Dr. Li is a wonderful young surgeon, who is not only brilliant, but also extremely caring and attentive to the overall well-being of his patients. He is also very responsive to questions. We would highly recommend Dr. Li to family & friends, and would give him a perfect 10!!

Dec 2016

•

Verified SHC Patient

I never could have imagined a more personable and genuine physician like Gordon Li. STill very impressed with outstanding care, time, patients, and support he demonstrated.

Oct 2016

•

Verified SHC Patient

Dr. Li has always been attentive to my needs and concerns.

Oct 2016

•

Verified SHC Patient

Dr. Li's skill, respect for his patient & family, calm and steady demeanor, and fact-based empathy make him a highly trusted doctor.

Oct 2016

•

Verified SHC Patient

Also the best.

Oct 2016

•

Verified SHC Patient

Very good.

Sep 2016

•

Verified SHC Patient

Care was excellent throughout.

Sep 2016

•

Verified SHC Patient

Very good thank you.

Sep 2016

•

Verified SHC Patient

Dr. Li is very supportive, caring and eager to work with me and support me 110%. He is open-minded and willing to think outside the box, exploring and discussing options to help me improve my health care issues and needs. He is awesome!!

Aug 2016

•

Verified SHC Patient

Exceeded expectations.

Jul 2016

•

Verified SHC Patient

Very nice couldn't be happier.

Jun 2016

•

Verified SHC Patient

Kind, gentle, respectful care was about average compared to any medical facility I'd experienced in my life time.

May 2016

•

Verified SHC Patient

Excellent doctor. Explained all procedures & medications with family. Couldn't ask for anything better. Very caring.

May 2016

•

Verified SHC Patient

Dr. Li is an exceptional doctor. he is an example for all doctors to model. he goes above and beyond for is patients - thank you Dr. Li for the amazing care & help you gave my father-in-law.

May 2016

•

Verified SHC Patient

I came 4 hours to have Dr. Li. I trust him with my life. So knowledgeable.

Mar 2016

•

Verified SHC Patient

Excellent attention.

Jan 2016

•

Verified SHC Patient

Dr. Li is wonderful, he is knowledgeable, and explains all risks and upsides.

Dec 2015

•

Verified SHC Patient

Dr. Li was one of the VERY BEST doctors I have seen in DECADES of good experience with Stanford Med Center doctors.

Dec 2015

•

Verified SHC Patient

Dr. Li has been outstanding!

Nov 2015

•

Verified SHC Patient

Excellent.

Nov 2015

•

Verified SHC Patient

Great experience.

Nov 2015

•

Verified SHC Patient

Dr. Li is excellent. He emails me directly to ask for my progress, and replies quickly. So problems can be quickly addressed.

Jul 2015

•

Verified SHC Patient

The clinic sets the best example for their patience.

Jun 2015

•

Verified SHC Patient

Dr. Gordon Li delivers the highest level of excellence in care with compassion, yet he is humble and approachable. I highly appreciate his care.

Feb 2015

•

Verified SHC Patient

Good experience.

Jan 2015

•

Verified SHC Patient

Was the 1st visit we were ever confident in provider or facility.

Jan 2015

•

Verified SHC Patient

Dr. Li is VERY GOOD.

Nov 2014

•

Verified SHC Patient

I would have liked a little more discussion about my condition, but understood that since I wasn't a surgical candidate, a referral to another dr. was approp.

Oct 2014

•

Verified SHC Patient

Dr. Gordon Li is outstanding! I love him! He is kind, attentive, knowledgeable, compassionate and so very capable! I and Stanford are so fortunate to have him as a dr. I wish all doctors were as awesome as he is!!

Aug 2014

•

Verified SHC Patient

Dr. Li was excellent, great bed side manner & actually listened to my concerns.

Jun 2014

•

Verified SHC Patient

If my condition takes a turn for the worse - I'll be back!

Feb 2014

•

Verified SHC Patient

All very good.

Feb 2014

•

Verified SHC Patient

Was never alone in exam room.

Dec 2013

•

Verified SHC Patient

View More Patient Reviews

Referring Physicians

PHYSICIAN HELPLINE

Phone: 1-866-742-4811
Fax: 650-320-9443
Monday–Friday, 8 a.m.–5 p.m.

Stanford Health Care provides comprehensive services to refer and track patients, as well as the latest information and news for physicians and office staff. For help with all referral needs and questions, visit Referral Information.

You may also submit a web referral or complete a referral form and fax it to 650-320-9443 or email the Referral Center at ReferralCenter@stanfordhealthcare.org.

Send referrals online
Place radiology and lab orders
View referral status
Access medical records

Learn More About MedLink

LOG INTO MEDLINK

New to MyHealth?

ALREADY HAVE AN ACCESS CODE?

DON'T HAVE AN ACCESS CODE?

NEED MORE DETAILS?

MyHealth for Mobile

Gordon Li, MD

Neurosurgeon

Get In Touch

Professional Summary

Education & Certifications

Honors & Awards

Administrative Appointments

Publications

Clinical Trials

Specializing In

Practice Locations

Brain and Spine Tumor Center at Stanford Neuroscience Health Center Palo Alto, CA

Brain and Spine Tumor Center at Stanford Neuroscience Health Center

CyberKnife Program at the Neuroscience Health Center Palo Alto, CA

CyberKnife Program at the Neuroscience Health Center

Skull Base Surgery at the Neuroscience Health Center Palo Alto, CA

Skull Base Surgery at the Neuroscience Health Center

Stanford Neuroscience Health Center Palo Alto, CA

Stanford Neuroscience Health Center

Neurocritical Care Program Stanford, CA

Neurocritical Care Program

Pituitary Center Palo Alto, CA

Pituitary Center

Neurosurgery Program Palo Alto, CA

Neurosurgery Program

Important Information about Our Organizations and Physician Affiliation

Patient Ratings

How Our Ratings Work

Patient Reviews

(222 reviews)

Referring Physicians

PHYSICIAN HELPLINE

New to MyHealth?

ALREADY HAVE AN ACCESS CODE?

DON'T HAVE AN ACCESS CODE?

NEED MORE DETAILS?

MyHealth for Mobile

WELCOME BACK

Gordon Li, MD

Neurosurgeon

Get In Touch

Professional Summary

Education & Certifications

Honors & Awards

Administrative Appointments

Publications

Clinical Trials

Specializing In

Practice Locations

Brain and Spine Tumor Center at Stanford Neuroscience Health Center Palo Alto, CA

Brain and Spine Tumor Center at Stanford Neuroscience Health Center

CyberKnife Program at the Neuroscience Health Center Palo Alto, CA

CyberKnife Program at the Neuroscience Health Center

Skull Base Surgery at the Neuroscience Health Center Palo Alto, CA

Skull Base Surgery at the Neuroscience Health Center

Stanford Neuroscience Health Center Palo Alto, CA

Stanford Neuroscience Health Center

Neurocritical Care Program Stanford, CA

Neurocritical Care Program

Pituitary Center Palo Alto, CA

Pituitary Center

Neurosurgery Program Palo Alto, CA

Neurosurgery Program

Important Information about Our Organizations and Physician Affiliation

Patient Ratings

How Our Ratings Work

Patient Reviews

(222 reviews)

Referring Physicians

PHYSICIAN HELPLINE